Join the 200th Anniversary Celebration

Original Article

Obstructive Sleep Apnea as a Risk Factor for Stroke and Death

H. Klar Yaggi, M.D., M.P.H., John Concato, M.D., M.P.H., Walter N. Kernan, M.D., Judith H. Lichtman, Ph.D., M.P.H., Lawrence M. Brass, M.D., and Vahid Mohsenin, M.D.

N Engl J Med 2005; 353:2034-2041November 10, 2005

Abstract

Background

Previous studies have suggested that the obstructive sleep apnea syndrome may be an important risk factor for stroke. It has not been determined, however, whether the syndrome is independently related to the risk of stroke or death from any cause after adjustment for other risk factors, including hypertension.

Methods

In this observational cohort study, consecutive patients underwent polysomnography, and subsequent events (strokes and deaths) were verified. The diagnosis of the obstructive sleep apnea syndrome was based on an apnea–hypopnea index of 5 or higher (five or more events per hour); patients with an apnea–hypopnea index of less than 5 served as the comparison group. Proportional-hazards analysis was used to determine the independent effect of the obstructive sleep apnea syndrome on the composite outcome of stroke or death from any cause.

Results

Among 1022 enrolled patients, 697 (68 percent) had the obstructive sleep apnea syndrome. At baseline, the mean apnea–hypopnea index in the patients with the syndrome was 35, as compared with a mean apnea–hypopnea index of 2 in the comparison group. In an unadjusted analysis, the obstructive sleep apnea syndrome was associated with stroke or death from any cause (hazard ratio, 2.24; 95 percent confidence interval, 1.30 to 3.86; P=0.004). After adjustment for age, sex, race, smoking status, alcohol-consumption status, body-mass index, and the presence or absence of diabetes mellitus, hyperlipidemia, atrial fibrillation, and hypertension, the obstructive sleep apnea syndrome retained a statistically significant association with stroke or death (hazard ratio, 1.97; 95 percent confidence interval, 1.12 to 3.48; P=0.01). In a trend analysis, increased severity of sleep apnea at baseline was associated with an increased risk of the development of the composite end point (P=0.005).

Conclusions

The obstructive sleep apnea syndrome significantly increases the risk of stroke or death from any cause, and the increase is independent of other risk factors, including hypertension.

Media in This Article

Figure 1Kaplan–Meier Estimates of the Probability of Event-free Survival among Patients with the Obstructive Sleep Apnea Syndrome and Controls.
Figure 2Kaplan–Meier Estimates of the Probability of Overall Survival among Patients with the Obstructive Sleep Apnea Syndrome and Controls.
Article

Stroke is the second leading cause of death worldwide and the leading cause of long-term disability.1,2 Strategies for stroke prevention, including the control of hypertension, treatment of atrial fibrillation, and smoking cessation, have reduced the disease burden, but stroke still remains an important public health challenge. A better understanding of the risk factors for stroke is needed to develop additional preventive strategies.

The obstructive sleep apnea syndrome is a treatable form of disordered breathing in which the upper airway closes repeatedly during sleep. The syndrome is associated with vascular risk factors and with substantial cardiovascular morbidity and mortality.3 Several studies have shown a prevalence of the syndrome among patients with stroke that exceeds 60 percent,4-7 as compared with 4 percent in the middle-aged adult population.8

Whether the relation between the syndrome and stroke is independent of confounding risk factors, such as hypertension, hyperlipidemia, diabetes mellitus, and smoking, is not clear. Several cross-sectional analyses6,9-14 have shown an increase in the risk of stroke with sleep-disordered breathing that is similar in magnitude to the effect of other cardiovascular risk factors. A study of patients with acute stroke7 demonstrated that obstructive apnea persisted despite neurologic recovery, suggesting that the obstructive sleep apnea syndrome may have predated the development of stroke. We therefore hypothesized that patients with the syndrome have an increased risk of stroke or death from any cause that is independent of other cerebrovascular risk factors.

Methods

Study Population

We conducted an observational cohort study. The cohort consisted of patients who were referred to the Yale Center for Sleep Medicine specifically for the evaluation of sleep-disordered breathing, underwent at least two hours of attended sleep monitoring, completed a 10-page questionnaire on their sleep and medical history, and were 50 or more years old. The exposure group was defined a priori as having an apnea–hypopnea index of 5 or higher (five or more events per hour of sleep); patients with an apnea–hypopnea index of less than 5 constituted the comparison group.

Patients were excluded if they had been referred for reasons other than the evaluation of suspected sleep-disordered breathing (e.g., narcolepsy or movement disorder); if they had a history of stroke, myocardial infarction, or tracheostomy; or if the entire polysomnographic study was performed with airway pressurization (e.g., continuous positive airway pressure for therapeutic purposes).

Participants or their family members gave either written or oral informed consent at the time of follow-up ascertainment. The study was approved by the Human Investigation Committee at Yale University School of Medicine.

Baseline Assessment

Data on demographic characteristics, sleep and medical history, medication use, and habits were obtained with the use of a standardized questionnaire administered by a trained technologist before the initiation of overnight polysomnography; the questionnaires were reviewed by a physician. Each patient's height and weight were recorded at the time of polysomnography and used to calculate the body-mass index.

Sleep-history data included a validated measure of daytime sleepiness (the Epworth Sleepiness Scale)15 and self-reported habitual snoring, which was defined as loud snoring occurring “frequently” or “constantly.” Data regarding medications included the daily use of beta-blockers, angiotensin-converting–enzyme inhibitors, other antihypertensive medications, antiplatelet therapy, anticoagulants, oral medications for the treatment of diabetes, insulin, and lipid-lowering medications. Risk-factor data included a history of hypertension, atrial fibrillation, diabetes mellitus, or hyperlipidemia, either reported by the patient on the baseline medical questionnaire or noted by the referring physician. In addition, atrial fibrillation on electrocardiography during polysomnography was considered sufficient evidence to establish that diagnosis.

Patients were classified according to whether they were current or former smokers or had never smoked; data were elicited, if applicable, on the number of pack-years of smoking. The history of alcohol consumption was based on the average number of drinks per day and the number of years of drinking.

Polysomnography

Participants underwent attended overnight polysomnography with the use of Grass data-acquisition systems (Astro-Med) on the basis of a protocol described previously.4 A single, attended polysomnographic study that was conducted during an entire night was used to establish the presence of sleep apnea.16 Sleep stages were scored in 30-second epochs according to standard criteria.17 Total cessation of airflow at the nose and mouth for at least 10 seconds was classified as apnea (as obstructive apnea if respiratory efforts were present and as central apnea if respiratory efforts were absent). Partial airway closure, resulting in a diminution of airflow by more than 30 percent for at least 10 seconds and associated with oxygen desaturation of 4 percent or more, was termed hypopnea.18 Calculated polysomnographic variables included the apnea–hypopnea index and the arousal index (the number of arousals per hour of sleep).

Outcomes

Each patient was sent a follow-up questionnaire, which included questions regarding current state of health, occurrence of stroke, hospitalizations, and treatment of sleep disorders since the baseline assessment. Strokes and transient ischemic attacks (TIA) were ascertained with the use of a validated questionnaire designed to be a practical and reliable means of ascertaining stroke status.19 Attempts were made to telephone patients who had not responded to the initial mailed questionnaire. Family members were asked to provide information about patients who were not able to participate owing to death, illness, or dementia.

A physician investigator who was unaware of the patient's status with regard to the obstructive sleep apnea syndrome validated reported strokes and TIAs by reviewing medical records. Diagnoses were determined according to criteria of the National Institute of Neurological Disorders and Stroke20 for the classification of cerebrovascular events. The exact date of the stroke or TIA was recorded. Vital records from the Connecticut Department of Public Health (regarding in-state deaths) and the Social Security Administration Death Master File21,22 (regarding out-of-state deaths) were used to determine or confirm death. The exact date of death was recorded.

Statistical Analysis

The primary outcome was the composite end point of incident stroke (including TIA, which hereafter will be reported as stroke) or death from any cause. With the assumption of a prevalence of 60 percent for sleep apnea in our cohort and an incidence of stroke per year of 1.5 percent23 during a four-year follow-up period, a sample of 840 patients was required in order to achieve 80 percent power to detect a relative risk of 2.0 at the 5 percent (two-tailed) significance level.

A series of prespecified time-to-event analyses were performed to examine the effect of the obstructive sleep apnea syndrome on the outcome. The time until the composite end point was taken to be the time until stroke, if the patient was contacted and found to have had a stroke, and the time until death, if the patient was not reached but was found to have died. Data were censored at the time of the contact if the patient was reached and was found not to have had a stroke and were censored at day 1 if the patient was not reached (or unwilling to be contacted) and was not found to have died.

The Kaplan–Meier method and the log-rank test were used to compare event-free survival among patients with and those without the obstructive sleep apnea syndrome. With the use of proportional-hazards analysis, hazard ratios and 95 percent confidence intervals were generated for the unadjusted association between sleep-apnea status or other baseline characteristics and the end point of stroke or death from any cause. Hazard ratios were then adjusted for the confounding effects of other baseline characteristics, including age, sex, race, smoking status, alcohol-consumption status, body-mass index, and the presence or absence of diabetes mellitus, hyperlipidemia, atrial fibrillation, and hypertension. Because of the possibility that controlling for hypertension could constitute “overadjustment” (i.e., accounting for a variable on the causal pathway),24 models were created both with and without the inclusion of hypertension. Finally, a trend analysis, with the use of the chi-square test for linear trend, was performed to analyze whether an increased severity of the obstructive sleep apnea syndrome (on the basis of quartiles of the apnea–hypopnea index) was associated with an increased risk of stroke or death from any cause.

Student's t-test was used to compare mean values at baseline among patients who had the obstructive sleep apnea syndrome with those in the comparison group. Categorical data were compared with the use of the chi-square test. All statistical tests were performed with the use of SAS software (SAS Institute). All reported P values are two-sided, and no interim analyses were conducted. S-Plus software was used to generate the Kaplan–Meier survival curves (Mathsoft Engineering and Education).

Results

Between January 1, 1997, and December 31, 2000, 3635 consecutive patients were referred to the sleep center, of whom 1022 were eligible to participate in the study. A total of 2402 patients were ineligible because they were less than 50 years of age, and 159 patients were ineligible because they had clinical evidence of previous myocardial infarction or stroke at entry. Another 52 patients were excluded because of unavailability of baseline data, having undergone a tracheostomy, or having been referred for conditions other than sleep-disordered breathing.

A total of 697 of the 1022 study participants (68 percent) were classified as having the obstructive sleep apnea syndrome (Table 1Table 1Baseline Characteristics of Patients with the Obstructive Sleep Apnea Syndrome and Controls.). The mean (±SD) apnea–hypopnea index among the patients with the syndrome was 35±29, as compared with 2.0±1.5 in the comparison group. As expected, the prevalence of hypertension and diabetes mellitus was higher in the group with the syndrome than in the comparison group (Table 1). Patients with the syndrome also were more obese, as reflected by the higher body-mass index, and had lower nadir oxygen saturations and a higher arousal index. Obstructive apnea was the predominant apneic event; central apnea was rare.

Many patients with the obstructive sleep apnea syndrome received some type of treatment for sleep apnea after the initial evaluation. Thirty-one percent achieved a weight reduction of 10 percent or more; 58 percent were using airway pressurization for at least four hours per night for five nights or more per week; 15 percent underwent upper-airway surgery.

Follow-up after the single sleep study took place between June 1, 2002, and December 31, 2003. Patients with the syndrome had a median duration of follow-up of 3.4 years (interquartile range, 2.6 to 3.9), and the comparison group had a median duration of follow-up of 3.3 years (interquartile range, 2.8 to 4.2). Among the 1022 study patients, data on stroke events and death from any cause were obtained for 842 patients (82 percent). Investigators were unable to contact the remaining 180 patients (18 percent), and the vital-records search did not indicate that they had died. This group included 124 patients with the syndrome and 56 patients in the comparison group. The baseline characteristics of these patients were similar to the characteristics of the group with complete follow-up (data not shown).

Incident stroke or death from any cause occurred in 88 patients (9 percent). The 88 confirmed events among these patients included 22 strokes and 50 deaths in the group with the obstructive sleep apnea syndrome (3.48 events per 100 person-years), as compared with 2 strokes and 14 deaths in the comparison group (1.60 events per 100 person-years). Figure 1Figure 1Kaplan–Meier Estimates of the Probability of Event-free Survival among Patients with the Obstructive Sleep Apnea Syndrome and Controls. shows the Kaplan–Meier estimates of the time to the composite event of stroke or death. The probability of event-free survival was significantly lower for patients with the syndrome than for the comparison group (P=0.003 by the log-rank test). A time-to-event analysis for death only showed a similar result (P=0.02 by the log-rank test) (Figure 2Figure 2Kaplan–Meier Estimates of the Probability of Overall Survival among Patients with the Obstructive Sleep Apnea Syndrome and Controls.).

In an unadjusted analysis (Table 2Table 2Unadjusted and Adjusted Hazard Ratios for the Risk of Stroke or Death from Any Cause.), a significant association was found between the obstructive sleep apnea syndrome and stroke or death from any cause (hazard ratio, 2.24; 95 percent confidence interval, 1.30 to 3.86; P=0.004). The associations of age and diabetes with the composite outcome were also statistically significant. The unadjusted hazard ratios for smoking, hypertension, and atrial fibrillation were in the expected direction, although not statistically significant. After adjustment for age, sex, race, smoking status, alcohol-consumption status, body-mass index, and the presence or absence of diabetes mellitus, hyperlipidemia, atrial fibrillation, and even hypertension, the obstructive sleep apnea syndrome retained a statistically significant association with stroke or death (hazard ratio, 1.97; 95 percent confidence interval, 1.12 to 3.48; P=0.01). The association of age with the outcomes also persisted after adjustment, but no statistically significant association was detected for other covariates. The inclusion of antiplatelet therapy in the model also did not influence the adjusted hazard ratio for the syndrome (data not shown).

A significant unadjusted association was found between the syndrome and death as a single end point (hazard ratio, 2.0; 95 percent confidence interval, 1.11 to 3.60; P=0.02). Adjusting for age, sex, race, smoking status, alcohol-consumption status, body-mass index, and the presence or absence of diabetes mellitus, hyperlipidemia, atrial fibrillation, and hypertension resulted in an attenuation of the hazard ratio for sleep apnea (1.70; 95 percent confidence interval, 0.92 to 3.16; P=0.09).

A trend analysis (Table 3Table 3Trend Analysis for the Relationship between Increased Severity of the Obstructive Sleep Apnea Syndrome and the Composite Outcome of Stroke or Death from Any Cause (N=1022).) revealed a stepwise increase in the risk of stroke or death from any cause as a function of increased severity of sleep apnea (P=0.005). The risk of stroke or death in patients in the most severe quartile of sleep apnea was three times that in the controls.

Discussion

We conducted a large observational cohort study examining the role of the obstructive sleep apnea syndrome in the development of a first stroke or death from any cause. Our results demonstrate that the syndrome is associated with an increased incidence of stroke or death from any cause and that the association is independent of other cardiovascular and cerebrovascular risk factors, including hypertension.

Our findings are consistent with recent data showing that severe obstructive sleep apnea syndrome increases the risk of fatal and nonfatal cardiovascular events.25 The broad range of severity of the syndrome in our study population allowed us to demonstrate an association between increased severity of the syndrome and increased risk of stroke or death from any cause. This correlation confirms the results of previous cross-sectional data showing that the risk of stroke appears to increase progressively with increased severity of the syndrome.14

In contrast to cross-sectional studies14 and studies that do not exclude preexisting cerebrovascular disease25 (which might reflect reverse causal pathways with the obstructive sleep apnea syndrome as the consequence, rather than the cause, of stroke), our study addressed the temporal relationship between the syndrome and stroke by including only first-time cerebrovascular events that occurred after initially abnormal results of a sleep study. The study also provides an assessment of the independent effect of sleep apnea. After an adjustment was made for cardiovascular risk factors in the multivariable model, the hazard ratio for stroke or death from any cause among patients with the obstructive sleep apnea syndrome remained significant. Although the association of the syndrome and death as a single end point was not statistically significant, the lower number of deaths as compared with the composite outcome probably reduced the ability to detect an independent effect. Overall, our results regarding the increased risk of death among patients with the obstructive sleep apnea syndrome are consistent with previous reports.26,27

The addition of hypertension to the model did not significantly attenuate the hazard ratio, suggesting that additional pathogenetic mechanisms (other than increased blood pressure) contribute to the increased risk of stroke and death. Possible mechanisms include acute hemodynamic changes during episodes of apnea,28,29 decreased cerebral blood flow,30-32 paradoxical embolization,33 hypercoagulability,34,35 hypoxia-related cerebral ischemia,36 and atherosclerosis.37

Several studies have demonstrated that airway pressurization (the main medical therapy for the syndrome) can reverse hypercoagulability34,35 and hemodynamic changes38-42 and even reduce the risk of cardiovascular events.25 The present study was not designed or powered to address adherence with treatment or the effect of treatment on outcomes. Nonetheless, our study demonstrated an increased risk of stroke or death from any cause among patients with the obstructive sleep apnea syndrome despite the administration of various therapies. Several explanations may account for this finding. First, it is likely that many of our patients had had untreated obstructive sleep apnea for years before seeking treatment, resulting in a prolonged exposure to cardiovascular risk. The median 3.4 years of follow-up may not have been a sufficient length of time to derive the potential cardiovascular therapeutic benefits. Second, reduced compliance with continuous positive airway pressure and limited efficacy of other treatments may have played a role in the failure of therapy to reduce the risk to baseline levels. Third, in contrast to the patients in a recent study that suggested a beneficial effect of treatment on outcomes,25 our population was older and had a higher prevalence of cardiovascular risk factors.

Several methodologic issues should be considered in the interpretation of our results. First, the ascertainment of stroke outcome was not possible in all patients. Some patients for whom death was reported as the outcome event may have had earlier, unreported strokes. The consequences of this methodologic limitation are reduced by an analysis that focuses on the combined end point of stroke or death, but it is nonetheless possible that strokes occurring much earlier in patients who died would alter the time-dependent character of the findings. A related issue involves possible nonfatal strokes among patients who were alive but were not contacted. However, the distribution of the obstructive sleep apnea syndrome between patients with and those without confirmed follow-up was nearly identical, suggesting that the results in patients who were lost to follow-up would be similar to those for the study population as a whole.

Second, it is possible that residual confounding factors affected our adjusted hazard ratios, despite our attempts to control for major cardiovascular risk factors. All the major known risk factors for stroke were considered in our analysis, so we think it is unlikely that an important confounder was overlooked.

Finally, some of the hazard ratios for known cardiovascular risk factors did not achieve statistical significance in our modeling. There are several possible reasons. First, patients with previous cardiovascular and cerebrovascular events were excluded from our cohort and the median 3.4 years of follow-up may not have been long enough for new events related to these traditional risk factors to develop in this cohort. Second, the concurrent treatment of these conditions probably reduced their effect on the composite outcome. Third, deaths from noncardiovascular causes (which were included in our composite outcome) may have reduced the measurable effect of traditional cardiovascular risk factors.

In conclusion, the obstructive sleep apnea syndrome is significantly associated with the risk of stroke or death from any cause, and this association is independent of other risk factors, including hypertension. Increased severity of the syndrome is associated with an incremental increase in the risk of this composite outcome.

Supported by a National Research Service Award Institutional Research Training Grant from the National Institutes of Health (5T32HL07778), by the Yale Center for Sleep Medicine, and by a career development award from the Veterans Affairs Health Services Research and Development Service (to Dr. Yaggi).

We are indebted to the staff of the Yale Center for Sleep Medicine for their valuable technical assistance; to the participants, whose cooperation made this study possible; and to Birol Emir, Ph.D., for his assistance in the preparation of the graphs.

Source Information

From the Section of Pulmonary and Critical Care Medicine, Yale Center for Sleep Medicine (H.K.Y., V.M.), the Section of General Medicine (J.C., W.N.K.), and the Departments of Epidemiology and Public Health (J.H.L., L.M.B.) and Neurology (L.M.B.), Yale University School of Medicine, New Haven, Conn.; and the Section of Pulmonary and Critical Care Medicine (H.K.Y.), the Clinical Epidemiology Research Center (H.K.Y., J.C.), and the Section of Neurology (L.M.B.), Veterans Affairs Connecticut Healthcare System, West Haven, Conn.

Address reprint requests to Dr. Mohsenin at the Yale Center for Sleep Medicine, 300 Cedar St., TAC 441, P.O. Box 208057, New Haven, CT 06520.

References

References

  1. 1

    Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997;349:1269-1276
    CrossRef | Web of Science | Medline

  2. 2

    Heart disease and stroke statistics — 2005 update. Dallas: American Heart Association, 2005.

  3. 3

    Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217-1239
    CrossRef | Web of Science | Medline

  4. 4

    Mohsenin V, Valor R. Sleep apnea in patients with hemispheric stroke. Arch Phys Med Rehabil 1995;76:71-76
    CrossRef | Web of Science | Medline

  5. 5

    Dyken ME, Somers VK, Yamada T, Ren ZY, Zimmerman MB. Investigating the relationship between stroke and obstructive sleep apnea. Stroke 1996;27:401-407
    CrossRef | Web of Science | Medline

  6. 6

    Bassetti C, Aldrich MS. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep 1999;22:217-223
    Web of Science | Medline

  7. 7

    Parra O, Arboix A, Bechich S, et al. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000;161:375-380
    Web of Science | Medline

  8. 8

    Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-1235
    Full Text | Web of Science | Medline

  9. 9

    Partinen M, Palomaki H. Snoring and cerebral infarction. Lancet 1985;2:1325-1326
    CrossRef | Web of Science | Medline

  10. 10

    Palomaki H. Snoring and the risk of ischemic brain infarction. Stroke 1991;22:1021-1025
    CrossRef | Web of Science | Medline

  11. 11

    Spriggs DA, French JM, Murdy JM, Curless RH, Bates D, James OF. Snoring increases the risk of stroke and adversely affects prognosis. Q J Med 1992;83:555-562
    Web of Science | Medline

  12. 12

    Smirne S, Palazzi S, Zucconi M, Chierchia S, Ferini-Strambi L. Habitual snoring as a risk factor for acute vascular disease. Eur Respir J 1993;6:1357-1361
    Web of Science | Medline

  13. 13

    Neau JP, Meurice JC, Paquereau J, Chavagnat JJ, Ingrand P, Gil R. Habitual snoring as a risk factor for brain infarction. Acta Neurol Scand 1995;92:63-68
    CrossRef | Web of Science | Medline

  14. 14

    Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25
    Web of Science | Medline

  15. 15

    Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea: the Epworth Sleepiness Scale. Chest 1993;103:30-36
    CrossRef | Web of Science | Medline

  16. 16

    Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research: the Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-689
    Web of Science | Medline

  17. 17

    Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: UCLA Brain Information Service/Brain Research Institute, 1968.

  18. 18

    Meoli AL, Casey KR, Clark RW, et al. Hypopnea in sleep-disordered breathing in adults. Sleep 2001;24:469-470
    Web of Science | Medline

  19. 19

    Meschia JF, Brott TG, Chukwudelunzu FE, et al. Verifying the stroke-free phenotype by structured telephone interview. Stroke 2000;31:1076-1080
    CrossRef | Web of Science | Medline

  20. 20

    Whisnant JD, Busford JR, Bernstein EF, Cooper ES, Dyken ML, Eastone D. National Institute of Neurological Disorders and Stroke special report: classification of cerebrovascular disease. Stroke 1990;21:637-676
    CrossRef | Medline

  21. 21

    Schisterman EF, Whitcomb BW. Use of the Social Security Administration Death Master File for ascertainment of mortality status. Popul Health Metr 2004;2:2-6
    CrossRef | Medline

  22. 22

    Social Security Death Index. (Accessed October 17, 2005, at http://www.ancestry.com/search/rectype/vital/ssdi/main.htm.)

  23. 23

    Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke 1998;29:415-421
    CrossRef | Web of Science | Medline

  24. 24

    Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-1384
    Full Text | Web of Science | Medline

  25. 25

    Marin JM, Carrizo SJ, Vincente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-1053
    CrossRef | Web of Science | Medline

  26. 26

    Lavie P, Herer P, Peled R, et al. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 1995;18:149-157
    Web of Science | Medline

  27. 27

    Marti S, Sampol G, Munoz X, et al. Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J 2002;20:1511-1518
    CrossRef | Web of Science | Medline

  28. 28

    Hedner J, Ejnell H, Sellgren J, Hedner T, Wallin G. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J Hypertens Suppl 1988;6:S529-S531
    Medline

  29. 29

    Leung RS, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 2001;164:2147-2165
    Web of Science | Medline

  30. 30

    Jennum P, Borgesen SE. Intracranial pressure and obstructive sleep apnea. Chest 1989;95:279-283
    CrossRef | Web of Science | Medline

  31. 31

    Netzer N, Werner P, Jochums I, Lehmann M, Strohl KP. Blood flow of the middle cerebral artery with sleep-disordered breathing: correlation with obstructive hypopneas. Stroke 1998;29:87-93
    CrossRef | Web of Science | Medline

  32. 32

    Franklin KA. Cerebral hemodynamics in obstructive sleep apnoea and Cheyne-Stokes respiration. Sleep Med Rev 2002;6:429-441
    CrossRef | Web of Science | Medline

  33. 33

    Beelke M, Angeli S, Del Sette M, et al. Obstructive sleep apnea can be provocative for right-to-left shunting through a patent foramen ovale. Sleep 2002;25:856-862
    Web of Science | Medline

  34. 34

    Bokinsky G, Miller M, Ault K, Husband P, Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: a preliminary investigation. Chest 1995;108:625-630
    CrossRef | Web of Science | Medline

  35. 35

    Chin K, Ohi M, Kita H, et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996;153:1972-1976
    Web of Science | Medline

  36. 36

    Kato M, Roberts-Thomson P, Phillips BG, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000;102:2607-2610
    Web of Science | Medline

  37. 37

    Hayashi M, Fujimoto K, Urushibata K, Uchikawa S, Imamura H, Kubo K. Nocturnal oxygen desaturation correlates with the severity of coronary atherosclerosis in coronary artery disease. Chest 2003;124:936-941
    CrossRef | Web of Science | Medline

  38. 38

    Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68-73
    CrossRef | Web of Science | Medline

  39. 39

    Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002;359:204-210
    CrossRef | Web of Science | Medline

  40. 40

    Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107:1129-1134
    CrossRef | Web of Science | Medline

  41. 41

    Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995;96:1897-1904
    CrossRef | Web of Science | Medline

  42. 42

    Diomedi M, Placidi F, Cupini LM, Bernardi G, Silvestrini M. Cerebral hemodynamic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment. Neurology 1998;51:1051-1056
    Web of Science | Medline

Citing Articles (346)

Citing Articles

  1. 1

    Christine H. Won, Hyung J. Chun, Suparna M. Chandra, Priscilla S. Sarinas, Rajinder K. Chitkara, Paul A. Heidenreich. (2012) Severe obstructive sleep apnea increases mortality in patients with ischemic heart disease and myocardial injury. Sleep and Breathing
    CrossRef

  2. 2

    Kristen L. Knutson, Xiongce Zhao, Megan Mattingly, Giulia Galli, Giovanni Cizza. (2012) Predictors of sleep-disordered breathing in obese adults who are chronic short sleepers. Sleep Medicine
    CrossRef

  3. 3

    Karthik Ananthasubramaniam, Robert Weiss, Bruce McNutt, Barbara Klauke, Kathleen Feaheny, Stan Bukofzer. (2012) A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease. Journal of Nuclear Cardiology
    CrossRef

  4. 4

    S. C. W. Tang, B. Lam, J. C. M. Lam, C. K. Chan, C. C. Chow, Y. W. Ho, M. S. M. Ip, K. N. Lai. (2012) Impact of nephrotic edema of the lower limbs on obstructive sleep apnea: gathering a unifying concept for the pathogenetic role of nocturnal rostral fluid shift. Nephrology Dialysis Transplantation
    CrossRef

  5. 5

    Richard B. Berry. 2012. Consequences of Obstructive Sleep Apnea and the Benefits of Treatment. , 281-298.
    CrossRef

  6. 6

    H. Klar Yaggi, Paul Dieffenbach. 2012. Sleep-Disordered Breathing and Cerebrovascular Disease. , 647-655.
    CrossRef

  7. 7

    Richard L. Verrier, Murray A. Mittleman. 2012. Sleep-Related Cardiac Disorders. , 585-594.
    CrossRef

  8. 8

    Maria Vittoria Davì, Andrea Giustina. (2012) Sleep apnea in acromegaly: a review on prevalence, pathogenetic aspects and treatment. Expert Review of Endocrinology & Metabolism 7:1, 55-62
    CrossRef

  9. 9

    Richard L. Horner. 2012. Neural Control of the Upper Airway: Integrative Physiological Mechanisms and Relevance for Sleep Disordered Breathing. .
    CrossRef

  10. 10

    Makoto Shiraishi, Hirofumi Watanabe, Kenzo Sakurai, Bunta Kato, Yasuhiro Hasegawa. (2012) Risk stratification of cardiovascular events in hypertensive patients with asymptomatic or symptomatic lacunar infarcts by 24-hour ambulatory blood pressure monitoring. Nosotchu 34:1, 1-7
    CrossRef

  11. 11

    Demin Han, Luo Zhang. (2011) Nasal cavity ventilation expansion techniques. Acta Oto-laryngologica 131:12, 1244-1248
    CrossRef

  12. 12

    Ivan Kopitovic, Nikola Trajanovic, Sinisa Prodic, Mirjana Jovancevic Drvenica, Miroslav Ilic, Vesna Kuruc, Marija Kojicic. (2011) The Serbian version of the Epworth Sleepiness Scale. Sleep and Breathing 15:4, 775-780
    CrossRef

  13. 13

    C. Savopoulos, K. Michalakis, M. Apostolopoulou, A. Miras, A. Hatzitolios. (2011) Adipokines and stroke: A review of the literature. Maturitas 70:4, 322-327
    CrossRef

  14. 14

    Chairat Neruntarat, Suprapol Chantapant. (2011) Prevalence of sleep apnea in HRH Princess Maha Chakri Srinthorn Medical Center, Thailand. Sleep and Breathing 15:4, 641-648
    CrossRef

  15. 15

    Laurent Poupard, Isabelle Court-Fortune, Vincent Pichot, Florian Chouchou, Jean-Claude Barthélémy, Frédéric Roche. (2011) Use of high-frequency peak in spectral analysis of heart rate increment to improve screening of obstructive sleep apnoea. Sleep and Breathing 15:4, 837-843
    CrossRef

  16. 16

    Jorge Rey de Castro, Edmundo Rosales-Mayor, Jenny Ferreyra-Pereyra. (2011) Using a generic measure of quality of life in patients with obstructive sleep apnea. Sleep and Breathing 15:4, 729-735
    CrossRef

  17. 17

    Amandine Ramond, Diane Godin-Ribuot, Christophe Ribuot, Perle Totoson, Irina Koritchneva, Sandrine Cachot, Patrick Levy, Marie Joyeux-Faure. (2011) Oxidative stress mediates cardiac infarction aggravation induced by intermittent hypoxia. Fundamental & Clinical Pharmacologyno-no
    CrossRef

  18. 18

    R. Muñoz, J. Durán-Cantolla, E. Martinez-Vila, J. Gállego, R. Rubio, F. Aizpuru, G. De La Torre, F. Barbé. (2011) Central sleep apnea is associated with increased risk of ischemic stroke in the elderly. Acta Neurologica Scandinavicano-no
    CrossRef

  19. 19

    Samreen Ahmed, He Meng, Tiecheng Liu, Blair C. Sutton, Mark R. Opp, Jimo Borjigin, Michael M. Wang. (2011) Ischemic stroke selectively inhibits REM sleep of rats. Experimental Neurology 232:2, 168-175
    CrossRef

  20. 20

    Gideon Sousa, Bernhard Schlüter, Thomas Menke, Eckardt Trowitzsch, Werner Andler, Thomas Reinehr. (2011) Longitudinal analyses of polysomnographic variables, serum androgens, and parameters of glucose metabolism in obese adolescents with polycystic ovarian syndrome. Sleep and Breathing
    CrossRef

  21. 21

    Maogang Chen, Bona Wu, Xinchun Ye, Zhiming Zhou, Xuanye Yue, Qizhang Wang, Wanxiang Wang, Yongjun Jiang, Xuegan Lian, Zhaoyao Chen, Gelin Xu, Xinfeng Liu. (2011) Association between plasma homocysteine levels and obstructive sleep apnoea in patients with ischaemic stroke. Journal of Clinical Neuroscience 18:11, 1454-1457
    CrossRef

  22. 22

    Ken Monahan, Susan Redline. (2011) Role of obstructive sleep apnea in cardiovascular disease. Current Opinion in Cardiology 26:6, 541-547
    CrossRef

  23. 23

    Prabhakaran Gopalakrishnan, Tahir Tak. (2011) Obstructive Sleep Apnea and Cardiovascular Disease. Cardiology in Review 19:6, 279-290
    CrossRef

  24. 24

    Richard L. Horner. 2011. Autonomic consequences of arousal from sleep and neural mechanisms of arousal. , 128-156.
    CrossRef

  25. 25

    Nalaka S. Gooneratne. 2011. Sleep apnea in older adults. , 399-417.
    CrossRef

  26. 26

    Eliot S. Katz, Carole L. Marcus. 2011. Obstructive sleep apnea: Children versus adults. , 370-398.
    CrossRef

  27. 27

    James M. Parish. (2011) Metabolic syndrome, obstructive sleep apnea, and risk of cardiovascular disease. Sleep and Breathing
    CrossRef

  28. 28

    Ira D. Davis, Larry A Greenbaum, Debbie Gipson, Lie Ling Wu, Rajiv Sinha, Mina Matsuda-Abedini, Judith L. Emancipator, Jerome C. Lane, Kavita Hodgkins, Corina Nailescu, Gina Marie Barletta, Steven Arora, John D. Mahan, Carol L. Rosen. (2011) Prevalence of sleep disturbances in children and adolescents with chronic kidney disease. Pediatric Nephrology
    CrossRef

  29. 29

    Olga Parra i Ordaz. (2011) Arguments Against AHI As an Independent Risk Factor for Sleepiness. Archivos de Bronconeumología (English Edition)
    CrossRef

  30. 30

    JI HO CHOI, JONG SOOK YI, SEUNG HOON LEE, CHEON SIK KIM, TAE HOON KIM, HEUNG MAN LEE, BONG-JAE LEE, SANG HAG LEE, YOO-SAM CHUNG. (2011) Effect of upper airway surgery on heart rate variability in patients with obstructive sleep apnoea syndrome. Journal of Sleep Researchno-no
    CrossRef

  31. 31

    Rute Sampaio, M. Graça Pereira, João C. Winck. (2011) Psychological morbidity, illness representations, and quality of life in female and male patients with obstructive sleep apnea syndrome. Psychology, Health & Medicine1-14
    CrossRef

  32. 32

    C. A. M. Medeiros, V. M. S. de Bruin, G. M. Andrade, W. M. Coutinho, C. de Castro-Silva, P. F. C. de Bruin. (2011) Obstructive sleep apnea and biomarkers of inflammation in ischemic stroke. Acta Neurologica Scandinavicano-no
    CrossRef

  33. 33

    N. Marina, A. P. L. Abdala, A. Korsak, A. E. Simms, A. M. Allen, J. F. R. Paton, A. V. Gourine. (2011) Control of sympathetic vasomotor tone by catecholaminergic C1 neurones of the rostral ventrolateral medulla oblongata. Cardiovascular Research 91:4, 703-710
    CrossRef

  34. 34

    Jimin Ding, Jürgen Symanzik, Abbass Sharif, Jia Wang, Stephen Duntley, William D. Shannon. (2011) Powerful actigraphy data through functional representation. CHANCE 24:3, 30-36
    CrossRef

  35. 35

    GIDEON DE SOUSA, BERNHARD SCHLÜTER, THOMAS MENKE, ECKARDT TROWITZSCH, WERNER ANDLER, THOMAS REINEHR. (2011) Relationships between polysomnographic variables, parameters of glucose metabolism, and serum androgens in obese adolescents with polycystic ovarian syndrome. Journal of Sleep Research 20:3, 472-478
    CrossRef

  36. 36

    Kavita Mundey, Shilpa Guggali, B. Tucker Woodson. (2011) Use of Portable Monitoring for Diagnosis and Follow-Up of Sleep-Disordered Breathing Treated With Upper Airway Surgery. Sleep Medicine Clinics 6:3, 341-347
    CrossRef

  37. 37

    S. Ballivet de Régloix, Y. Pons, F. Chabolle, P. Clément, O. Maurin, C. Conessa. (2011) Syndrome d’apnées obstructives du sommeil. Étude de pratiques en médecine générale. Une enquête descriptive auprès de 108 praticiens militaires. Revue des Maladies Respiratoires 28:7, 885-893
    CrossRef

  38. 38

    Akira Matsuo, Yuichi Inoue, Kazuyoshi Namba, Hiroshige Chiba. (2011) Changes in cerebral hemoglobin indices in obstructive sleep apnea syndrome with nasal continuous positive airway pressure treatment. Sleep and Breathing 15:3, 487-492
    CrossRef

  39. 39

    Mayris P. Webber, Roy Lee, Jackie Soo, Jackson Gustave, Charles B. Hall, Kerry Kelly, David Prezant. (2011) Prevalence and incidence of high risk for obstructive sleep apnea in World Trade Center-exposed rescue/recovery workers. Sleep and Breathing 15:3, 283-294
    CrossRef

  40. 40

    Peter Johansson, Urban Alehagen, Martin Ulander, Eva Svanborg, Ulf Dahlström, Anders Broström. (2011) Sleep disordered breathing in community dwelling elderly: Associations with cardiovascular disease, impaired systolic function, and mortality after a six-year follow-up. Sleep Medicine 12:8, 748-753
    CrossRef

  41. 41

    F. Lally, A. Thakkar, C. Roffe. (2011) Sleep apnoea and stroke. Somnologie - Schlafforschung und Schlafmedizin 15:3, 148-153
    CrossRef

  42. 42

    Shu-zhi Feng, Jian-li Tian, Qiang Zhang, Hui Wang, Ning Sun, Yun Zhang, Bao-yuan Chen. (2011) An experimental research on chronic intermittent hypoxia leading to liver injury. Sleep and Breathing 15:3, 493-502
    CrossRef

  43. 43

    Theresa Mayes, Michele M. Gottschlich, Jane Khoury, John McCall, Narong Simakajornboon, Richard J. Kagan. (2011) Sleep Apnea: A Risk Factor for Obese Burned Children During the Rehabilitative Phase of Injury. Journal of Burn Care & Research 32:5, 541-546
    CrossRef

  44. 44

    Tonya Russell, Stephen Duntley. (2011) Sleep Disordered Breathing in the Elderly. The American Journal of Medicine
    CrossRef

  45. 45

    B. Fuentes, J. Gallego, A. Gil-Nuñez, A. Morales, F. Purroy, J. Roquer, T. Segura, J. Tejada, A. Lago, E. Díez-Tejedor. (2011) Guía para el tratamiento preventivo del ictus isquémico y AIT (I). Actuación sobre los factores de riesgo y estilo de vida. Neurología
    CrossRef

  46. 46

    Anna Svatikova, Renuka Jain, Ronald D. Chervin, Peter G. Hagan, Devin L. Brown. (2011) Echocardiographic findings in ischemic stroke patients with obstructive sleep apnea. Sleep Medicine 12:7, 700-703
    CrossRef

  47. 47

    Robert Thurnheer. (2011) Diagnostic approach to sleep-disordered breathing. Expert Review of Respiratory Medicine 5:4, 573-589
    CrossRef

  48. 48

    John J. Sim, Eric H. Yan, In Lu A. Liu, Scott A. Rasgon, Kamyar Kalantar-Zadeh, David A. Calhoun, Stephen F. Derose. (2011) Positive relationship of sleep apnea to hyperaldosteronism in an ethnically diverse population. Journal of Hypertension 29:8, 1553-1559
    CrossRef

  49. 49

    Khaldon Lweesy, Luay Fraiwan, Natheer Khasawneh, Hartmut Dickhaus. (2011) New Automated Detection Method of OSA Based on Artificial Neural Networks Using P-Wave Shape and Time Changes. Journal of Medical Systems 35:4, 723-734
    CrossRef

  50. 50

    Nathaniel S Marshall, Julian G Ayer, Brett G Toelle, Jason A Harmer, Craig L Phillips, Ronald R Grunstein, David S Celermajer, Guy B Marks. (2011) Snoring is not associated with adverse effects on blood pressure, arterial structure or function in 8-year-old children: The Childhood Asthma Prevention Study (CAPS). Journal of Paediatrics and Child Health 47:8, 518-523
    CrossRef

  51. 51

    Joseph Yeboah, Susan Redline, Craig Johnson, Russell Tracy, Pamela Ouyang, Roger S. Blumenthal, Gregory L. Burke, David M. Herrington. (2011) Association between sleep apnea, snoring, incident cardiovascular events and all-cause mortality in an adult population: MESA. Atherosclerosis
    CrossRef

  52. 52

    Denis Martinez, Cristini Klein, Laura Rahmeier, Roberto Pacheco Silva, Cintia Zappe Fiori, Cristiane Maria Cassol, Sandro Cadaval Gonçalves, Angelo Jose Goncalves Bos. (2011) Sleep apnea is a stronger predictor for coronary heart disease than traditional risk factors. Sleep and Breathing
    CrossRef

  53. 53

    T. Masuda, M. Murata, S. Honma, Y. Iwazu, N. Sasaki, M. Ogura, A. Onishi, Y. Ando, S. Muto, K. Shimada, K. Kario, E. Kusano, Y. Asano. (2011) Sleep-disordered breathing predicts cardiovascular events and mortality in hemodialysis patients. Nephrology Dialysis Transplantation 26:7, 2289-2295
    CrossRef

  54. 54

    Olga Parra i Ordaz. (2011) IAH como factor de riesgo independiente de la somnolencia. Argumentos en contra. Archivos de Bronconeumología
    CrossRef

  55. 55

    F. Mallamaci, G. Tripepi. (2011) Comment accompanying: obstructive sleep apnoea: a stand-alone risk factor for chronic kidney disease by Chou Yu-Ting. Nephrology Dialysis Transplantation 26:7, 2072-2074
    CrossRef

  56. 56

    Claudia Alves, José Manuel Pinto Chaves Caminha, Antonio Martins Silva, Denisa Mendonça. (2011) Compliance to continuous positive airway pressure therapy in a group of Portuguese patients with obstructive sleep apnea syndrome. Sleep and Breathing
    CrossRef

  57. 57

    Katharina Pirklbauer, Guenter Russmueller, Leopold Stiebellehner, Christina Nell, Klaus Sinko, Gabriele Millesi, Clemens Klug. (2011) Maxillomandibular Advancement for Treatment of Obstructive Sleep Apnea Syndrome: A Systematic Review. Journal of Oral and Maxillofacial Surgery 69:6, e165-e176
    CrossRef

  58. 58

    Gideon de Sousa, Bernhard Schlüter, Thomas Menke, Eckardt Trowitzsch, Werner Andler, Thomas Reinehr. (2011) A Comparison of Polysomnographic Variables Between Adolescents with Polycystic Ovarian Syndrome with and without the Metabolic Syndrome. Metabolic Syndrome and Related Disorders 9:3, 191-196
    CrossRef

  59. 59

    Danny J. Eckert, Robert L. Owens, Geoffrey B. Kehlmann, Andrew Wellman, Shilpa Rahangdale, Susie YimYeh, David P. White, Atul Malhotra. (2011) Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold. Clinical Science 120:12, 505-514
    CrossRef

  60. 60

    Kishor Gandhi, James W. Heitz, Eugene R. Viscusi. (2011) Challenges in Acute Pain Management. Anesthesiology Clinics 29:2, 291-309
    CrossRef

  61. 61

    Judith L. Meadows, Douglas E. Vaughan. (2011) Endothelial biology in the post-menopausal obese woman. Maturitas 69:2, 120-125
    CrossRef

  62. 62

    Ann M. Stowe, Tamer Altay, Angela B. Freie, Jeffrey M. Gidday. (2011) Repetitive hypoxia extends endogenous neurovascular protection for stroke. Annals of Neurology 69:6, 975-985
    CrossRef

  63. 63

    Ryo Naito, Kenichi Sakakura, Takatoshi Kasai, Tomotaka Dohi, Hiroshi Wada, Yoshitaka Sugawara, Norifumi Kubo, Suguru Yamashita, Koji Narui, Sugao Ishiwata, Minoru Ohno, Junya Ako, Shin-ichi Momomura. (2011) Aortic dissection is associated with intermittent hypoxia and re-oxygenation. Heart and Vessels
    CrossRef

  64. 64

    Michiel H. J. Doff, Steffanie K. B. Veldhuis, Aarnoud Hoekema, James J. R. Huddleston Slater, P. J. Wijkstra, Lambert G. M. Bont, Boudewijn Stegenga. (2011) Long-term oral appliance therapy in obstructive sleep apnea syndrome: a controlled study on temporomandibular side effects. Clinical Oral Investigations
    CrossRef

  65. 65

    Vahid Mohsenin, Fred Urbano. (2011) Circulating antiangiogenic proteins in obstructive sleep apnea and hypertension. Respiratory Medicine 105:5, 801-807
    CrossRef

  66. 66

    Tawfiq Zeidan-Shwiri, Doron Aronson, Khalid Atalla, Miry Blich, Mahmoud Suleiman, Ibrahim Marai, Lior Gepstein, Lena Lavie, Peretz Lavie, Monther Boulos. (2011) Circadian pattern of life-threatening ventricular arrhythmia in patients with sleep-disordered breathing and implantable cardioverter-defibrillators. Heart Rhythm 8:5, 657-662
    CrossRef

  67. 67

    S Choudhury, S Taheri. (2011) Obstructive sleep apnoea and type 2 diabetes: whose disease is it anyway?. Practical Diabetes International 28:4, 183-186a
    CrossRef

  68. 68

    Jeffrey M. Tanner, Tina I. Chang, Nancy D. Harada, Silverio M. Santiago, Jane E. Weinreb, Arthur H. Friedlander. (2011) Prevalence of Comorbid Obstructive Sleep Apnea and Metabolic Syndrome: Syndrome Z and Maxillofacial Surgery Implications. Journal of Oral and Maxillofacial Surgery
    CrossRef

  69. 69

    Jing Feng, Dan Zhang, Baoyuan Chen. (2011) Endothelial mechanisms of endothelial dysfunction in patients with obstructive sleep apnea. Sleep and Breathing
    CrossRef

  70. 70

    Cyril Pellaton, Raphaël Heinzer, Patrik Michel, Eric Eeckhout. (2011) Patent foramen ovale and obstructive sleep apnoea: From pathophysiology to diagnosis of a potentially dangerous association. Archives of Cardiovascular Diseases 104:4, 242-251
    CrossRef

  71. 71

    Puja Kohli, Jay S. Balachandran, Atul Malhotra. (2011) Obstructive Sleep Apnea and the Risk for Cardiovascular Disease. Current Atherosclerosis Reports 13:2, 138-146
    CrossRef

  72. 72

    M. Vicente. (2011) Conséquences du syndrome d’apnées obstructives du sommeil sur la récupération fonctionnelle et la survie après un infarctus cérébral sus-tentoriel et impact du traitement par pression positive continue. Médecine du Sommeil 8:2, 58-60
    CrossRef

  73. 73

    Hirokazu Saruhara, Yoshifumi Takata, Yasuhiro Usui, Kazuki Shiina, Yuki Hashimura, Kota Kato, Kihiro Asano, Satoshi Kawaguchi, Yukio Obitsu, Hiroshi Shigematsu, Akira Yamashina. (2011) Obstructive sleep apnea as a potential risk factor for aortic disease. Heart and Vessels
    CrossRef

  74. 74

    G.E. Vries, P.M. Meijer, B. Stegenga, J.H. Hoeven, R.A. Feijen, P.J. Wijkstra. (2011) Obstructief slaapapneusyndroom (OSAS): definitie, diagnostiek en behandeling. Bijblijven 27:1, 51-58
    CrossRef

  75. 75

    Kate Crowley. (2011) Sleep and Sleep Disorders in Older Adults. Neuropsychology Review 21:1, 41-53
    CrossRef

  76. 76

    Patricia Lloberes, Joaquín Durán-Cantolla, Miguel Ángel Martínez-García, José María Marín, Antoni Ferrer, Jaime Corral, Juan Fernando Masa, Olga Parra, Mari Luz Alonso-Álvarez, Joaquín Terán-Santos. (2011) Diagnóstico y tratamiento del síndrome de apneas-hipopneas del sueño. Archivos de Bronconeumología 47:3, 143-156
    CrossRef

  77. 77

    Izabela Tuleta, Stefan Pabst, Uwe R. Juergens, Georg Nickenig, Dirk Skowasch. (2011) Obstructive sleep apnoea as a risk factor for atherosclerosis – implication for preventive and personalised treatment. The EPMA Journal 2:1, 39-47
    CrossRef

  78. 78

    Ghada Bourjeily, Gina Ankner, Vahid Mohsenin. (2011) Sleep-disordered Breathing in Pregnancy. Clinics in Chest Medicine 32:1, 175-189
    CrossRef

  79. 79

    B. Lamia, J.-C. Meurice. (2011) Pathologie respiratoire du sommeil. Revue des Maladies Respiratoires Actualités 3:1, 2-13
    CrossRef

  80. 80

    Kristian Barlinn, Andrei V. Alexandrov. (2011) Sleep-disordered breathing and arterial blood flow steal represent linked therapeutic targets in cerebral ischaemia. International Journal of Stroke 6:1, 40-41
    CrossRef

  81. 81

    N. H. Rod, J. Vahtera, H. Westerlund, M. Kivimaki, M. Zins, M. Goldberg, T. Lange. (2011) Sleep Disturbances and Cause-Specific Mortality: Results From the GAZEL Cohort Study. American Journal of Epidemiology 173:3, 300-309
    CrossRef

  82. 82

    Olivier M. Vanderveken, An Boudewyns, Quan Ni, Bhavani Kashyap, Johan Verbraecken, Wilfried Backer, Paul Heyning. (2011) Cardiovascular Implications in the Treatment of Obstructive Sleep Apnea. Journal of Cardiovascular Translational Research 4:1, 53-60
    CrossRef

  83. 83

    , Jing Feng, Quan-ying He, Xi-long Zhang, Bao-yuan Chen. (2011) Epworth Sleepiness Scale may be an indicator for blood pressure profile and prevalence of coronary artery disease and cerebrovascular disease in patients with obstructive sleep apnea. Sleep and Breathing
    CrossRef

  84. 84

    Gideon Sousa, Bernhard Schlüter, Dirk Buschatz, Thomas Menke, Eckardt Trowitzsch, Werner Andler, Thomas Reinehr. (2011) The impact of insulin resistance and hyperandrogenemia on polysomnographic variables in obese adolescents with polycystic ovarian syndrome. Sleep and Breathing
    CrossRef

  85. 85

    Denis Martinez, Roberto Pacheco Silva, Cristini Klein, Cintia Zappe Fiori, Daniela Massierer, Cristiane Maria Cassol, Angelo Jose Gonçalves Bos, Miguel Gus. (2011) High risk for sleep apnea in the Berlin questionnaire and coronary artery disease. Sleep and Breathing
    CrossRef

  86. 86

    Claudio L. Bassetti. 2011. Sleep and Stroke. , 993-1015.
    CrossRef

  87. 87

    John M. Dopp, Nathan R. Philippi, Noah J. Marcus, E. Burt Olson, Cynthia E. Bird, John J.M. Moran, Scott W. Mueller, Barbara J. Morgan. (2011) Xanthine Oxidase Inhibition Attenuates Endothelial Dysfunction Caused by Chronic Intermittent Hypoxia in Rats. Respiration 82:5, 458-467
    CrossRef

  88. 88

    Barbara A. Phillips, Meir H. Kryger. 2011. Management of Obstructive Sleep Apnea–Hypopnea Syndrome. , 1278-1293.
    CrossRef

  89. 89

    Seockhoon Chung, In-Young Yoon, Chul Hee Lee, Jeong-Whun Kim. (2011) The effects of nasal continuous positive airway pressure on vascular functions and serum cardiovascular risk factors in obstructive sleep apnea syndrome. Sleep and Breathing 15:1, 71-76
    CrossRef

  90. 90

    Patricia Lloberes, Joaquín Durán-Cantolla, Miguel Ángel Martínez-García, José María Marín, Antoni Ferrer, Jaime Corral, Juan Fernando Masa, Olga Parra, Mari Luz Alonso-Álvarez, Joaquín Terán-Santos. (2011) Diagnosis and treatment of sleep apnea-hypopnea syndrome. Archivos de Bronconeumología (English Edition) 47:3, 143-156
    CrossRef

  91. 91

    Barbara S. Gold. (2011) Preoperative Evaluation of the Adult Outpatient. ASA Refresher Courses in Anesthesiology 39:1, 57-64
    CrossRef

  92. 92

    Byung-Euk Joo, Hung Youl Seok, Sung-Wook Yu, Byung-Jo Kim, Kun-Woo Park, Dae-Hie Lee, Ki-Young Jung. (2011) Prevalence of sleep-disordered breathing in acute ischemic stroke as determined using a portable sleep apnea monitoring device in Korean subjects. Sleep and Breathing 15:1, 77-82
    CrossRef

  93. 93

    Barbara A. Phillips. 2011. Obstructive Sleep Apnea in the Elderly. , 1536-1543.
    CrossRef

  94. 94

    Kensaku Shibazaki, Kazumi Kimura, Junichi Uemura, Kenichiro Sakai, Yuki Sakamoto, Shuichi Fujii. (2011) Sleep-disordered breathing in patients with cerebrovascular disease. Nosotchu 33:5, 488-494
    CrossRef

  95. 95

    Susie Yim-Yeh, Shilpa Rahangdale, Anh Tu Duy Nguyen, Karen E. Stevenson, Victor Novack, Aristidis Veves, Atul Malhotra. (2011) Vascular Dysfunction in Obstructive Sleep Apnea and Type 2 Diabetes Mellitus. Obesity 19:1, 17-22
    CrossRef

  96. 96

    Claudio Vicini, Iacopo Dallan, Pietro Canzi, Sabrina Frassineti, Andrea Nacci, Veronica Seccia, Erica Panicucci, Maria Grazia La Pietra, Filippo Montevecchi, Manfred Tschabitscher. (2011) Transoral robotic surgery of the tongue base in obstructive sleep Apnea-Hypopnea syndrome: Anatomic considerations and clinical experience. Head & Neckn/a-n/a
    CrossRef

  97. 97

    Robin J. Trupp, Elizabeth J. Corwin, Karen L. Ahijevych, Thomas Nygren. (2010) The Impact of Educational Message Framing on Adherence to Continuous Positive Airway Pressure Therapy. Behavioral Sleep Medicine 9:1, 38-52
    CrossRef

  98. 98

    Edmund M.T. Lau, Brendon J. Yee, Ronald R. Grunstein, David S. Celermajer. (2010) Patent foramen ovale and obstructive sleep apnea: A new association?. Sleep Medicine Reviews 14:6, 391-395
    CrossRef

  99. 99

    Francoise J. Roux, Meir H. Kryger. (2010) Therapeutics for Sleep-disordered Breathing. Sleep Medicine Clinics 5:4, 647-657
    CrossRef

  100. 100

    S.M. Susarla, R.J. Thomas, Z.R. Abramson, L.B. Kaban. (2010) Biomechanics of the upper airway: Changing concepts in the pathogenesis of obstructive sleep apnea. International Journal of Oral and Maxillofacial Surgery 39:12, 1149-1159
    CrossRef

  101. 101

    M.H.J. Doff, A. Hoekema, G.J. Pruim, J.J.R. Huddleston Slater, B. Stegenga. (2010) Long-term oral-appliance therapy in obstructive sleep apnea: A cephalometric study of craniofacial changes. Journal of Dentistry 38:12, 1010-1018
    CrossRef

  102. 102

    Kanika Bagai. (2010) Obstructive Sleep Apnea, Stroke, and Cardiovascular Diseases. The Neurologist 16:6, 329-339
    CrossRef

  103. 103

    Péter Torzsa, László Kalabay, Ágnes Ádám, Márta Novák, István Mucsi. (2010) Az obstruktív alvási apnoe klinikai jelentősége, a családorvos szerepe a betegek kezelésében, valamint gondozásában. Orvosi Hetilap 151:42, 1725-1733
    CrossRef

  104. 104

    Marishka K. Brown, Nirinjini Naidoo. (2010) The UPR and the Anti-oxidant Response: Relevance to Sleep and Sleep Loss. Molecular Neurobiology 42:2, 103-113
    CrossRef

  105. 105

    Gbemisola A. Adeseun, Sylvia E. Rosas. (2010) The Impact of Obstructive Sleep Apnea on Chronic Kidney Disease. Current Hypertension Reports 12:5, 378-383
    CrossRef

  106. 106

    Richard C. Becker. (2010) A clinical cardiology perspective of thrombophilias. Journal of Thrombosis and Thrombolysis 30:3, 378-389
    CrossRef

  107. 107

    Sushmita Pamidi, Renee S. Aronsohn, Esra Tasali. (2010) Obstructive sleep apnea: Role in the risk and severity of diabetes. Best Practice & Research Clinical Endocrinology & Metabolism 24:5, 703-715
    CrossRef

  108. 108

    Jian-Hua Zhang, Simon J. Fung, Mingchu Xi, Sharon Sampogna, Michael H. Chase. (2010) Apnea produces neuronal degeneration in the pons and medulla of guinea pigs. Neurobiology of Disease 40:1, 251-264
    CrossRef

  109. 109

    Luciano F. Drager, Jonathan C. Jun, Vsevolod Y. Polotsky. (2010) Metabolic consequences of intermittent hypoxia: Relevance to obstructive sleep apnea. Best Practice & Research Clinical Endocrinology & Metabolism 24:5, 843-851
    CrossRef

  110. 110

    Hui Xie, Kin-Ling Leung, Lei Chen, Ying-Shing Chan, Pak-Cheung Ng, Tai-Fai Fok, Yun-Kwok Wing, Ya Ke, Albert M. Li, Wing-Ho Yung. (2010) Brain-derived neurotrophic factor rescues and prevents chronic intermittent hypoxia-induced impairment of hippocampal long-term synaptic plasticity. Neurobiology of Disease 40:1, 155-162
    CrossRef

  111. 111

    Miguel Ángel Martínez-García, Joaquín Durán-Cantolla, José María Montserrat. (2010) El síndrome de apneas-hipopneas durante el sueño en edades avanzadas. Archivos de Bronconeumología 46:9, 479-488
    CrossRef

  112. 112

    Michael J. Decker, Shulamit Eyal, Zvika Shinar, Yair Fuxman, Clement Cahan, William C. Reeves, Anda Baharav. (2010) Validation of ECG-derived sleep architecture and ventilation in sleep apnea and chronic fatigue syndrome. Sleep and Breathing 14:3, 233-239
    CrossRef

  113. 113

    Alessandra Quercioli, François Mach, Fabrizio Montecucco. (2010) Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS). Sleep and Breathing 14:3, 261-269
    CrossRef

  114. 114

    Seckin O. Ulualp. (2010) Snoring and Obstructive Sleep Apnea. Medical Clinics of North America 94:5, 1047-1055
    CrossRef

  115. 115

    Kyoung Bin Im, Scott Strader, Mark Eric Dyken. (2010) Management of Sleep Disorders in Stroke. Current Treatment Options in Neurology 12:5, 379-395
    CrossRef

  116. 116

    Hrayr Attarian. (2010) Reevaluating Obstructive Sleep Apnea as a Risk Factor for Cerebrovascular Disease. Journal of Stroke and Cerebrovascular Diseases 19:5, 337-339
    CrossRef

  117. 117

    Jacek Wolf, Dagmara Hering, Krzysztof Narkiewicz. (2010) Non-dipping pattern of hypertension and obstructive sleep apnea syndrome. Hypertension Research 33:9, 867-871
    CrossRef

  118. 118

    Ina Djonlagic, Atul Malhotra. (2010) Risk of stroke from sleep apnea in men and women. Expert Review of Neurotherapeutics 10:8, 1267-1271
    CrossRef

  119. 119

    K Gaddam, E Pimenta, S J Thomas, S S Cofield, S Oparil, S M Harding, D A Calhoun. (2010) Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. Journal of Human Hypertension 24:8, 532-537
    CrossRef

  120. 120

    David E. Green, David A. Schulman. (2010) Obstructive Sleep Apnea and Cardiovascular Disease. Current Treatment Options in Cardiovascular Medicine 12:4, 342-354
    CrossRef

  121. 121

    Alberto Ramos-Sepulveda, William Wohlgemuth, Hannah Gardener, Dalia Lorenzo, Salim Dib, Douglas M. Wallace, Bruce Nolan, Bernadette Boden-Albala, Mitchell S. V. Elkind, Ralph L. Sacco, Tatjana Rundek. (2010) Snoring and insomnia are not associated with subclinical atherosclerosis in the Northern Manhattan Study. International Journal of Stroke 5:4, 264-268
    CrossRef

  122. 122

    M. C. Johnson, F. J. Kirkham, S. Redline, C. L. Rosen, Y. Yan, I. Roberts, J. Gruenwald, J. Marek, M. R. DeBaun. (2010) Left ventricular hypertrophy and diastolic dysfunction in children with sickle cell disease are related to asleep and waking oxygen desaturation. Blood 116:1, 16-21
    CrossRef

  123. 123

    Girardin Jean-Louis, Clinton D Brown, Ferdinand Zizi, Gbenga Ogedegbe, Carla Boutin-Foster, Joseph Gorga, Samy I McFarlane. (2010) Cardiovascular disease risk reduction with sleep apnea treatment. Expert Review of Cardiovascular Therapy 8:7, 995-1005
    CrossRef

  124. 124

    DAN HURLEY. (2010) Increased TNF Levels Found to Be Mechanism Behind Apnea-Stroke Link. Neurology Today 10:13, 13
    CrossRef

  125. 125

    Brian B. Koo, Kingman P. Strohl, Carl B. Gillombardo, Frank J. Jacono. (2010) Ventilatory patterning in a mouse model of stroke. Respiratory Physiology & Neurobiology 172:3, 129-135
    CrossRef

  126. 126

    Dan J. Capampangan, Kay E. Wellik, James M. Parish, Maria I. Aguilar, Charlene R. Hoffman Snyder, Dean Wingerchuk, Bart M. Demaerschalk. (2010) Is Obstructive Sleep Apnea an Independent Risk Factor for Stroke?. The Neurologist 16:4, 269-273
    CrossRef

  127. 127

    Kim H Chan, Ian Wilcox. (2010) Obstructive sleep apnea: novel trigger and potential therapeutic target for cardiac arrhythmias. Expert Review of Cardiovascular Therapy 8:7, 981-994
    CrossRef

  128. 128

    Bharati Prasad, David W. Carley, James J. Herdegen. (2010) Continuous positive airway pressure device-based automated detection of obstructive sleep apnea compared to standard laboratory polysomnography. Sleep and Breathing 14:2, 101-107
    CrossRef

  129. 129

    Neomi A. Shah, Henry Klar Yaggi, John Concato, Vahid Mohsenin. (2010) Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death. Sleep and Breathing 14:2, 131-136
    CrossRef

  130. 130

    Bernabé Jurado Gámez, José Luis Gómez-Chaparro Moreno, María Muñoz Calero, Julia Ruiz Laguna, Luis Muñoz Cabrera, Andrés Cosano Povedano, Juan López-Barea. (2010) Variación de la expresión proteica en función de la gravedad del síndrome de apnea-hipopnea del sueño. Archivos de Bronconeumología 46:6, 288-293
    CrossRef

  131. 131

    Bernardo Selim, Christine Won, H. Klar Yaggi. (2010) Cardiovascular Consequences of Sleep Apnea. Clinics in Chest Medicine 31:2, 203-220
    CrossRef

  132. 132

    Bernabé Jurado Gámez, José Luis Gómez-Chaparro Moreno, María Muñoz Calero, Julia Ruiz Laguna, Luis Muñoz Cabrera, Andrés Cosano Povedano, Juan López-Barea. (2010) Variation in Protein Expression Depending on the Severity of Sleep Apnoea-Hypopnoea Syndrome. Archivos de Bronconeumología (English Edition) 46:6, 288-293
    CrossRef

  133. 133

    Sydney C W Tang, Bing Lam, Tzy Jyun Yao, Wah Shing Leung, Chung Ming Chu, Yiu Wing Ho, Mary S M Ip, Kar Neng Lai. (2010) Sleep apnea is a novel risk predictor of cardiovascular morbidity and death in patients receiving peritoneal dialysis. Kidney International 77:11, 1031-1038
    CrossRef

  134. 134

    H. Klar Yaggi, Kingman P. Strohl. (2010) Adult Obstructive Sleep Apnea/Hypopnea Syndrome: Definitions, Risk Factors, and Pathogenesis. Clinics in Chest Medicine 31:2, 179-186
    CrossRef

  135. 135

    Sakiko Inamoto, Toshitaka Yoshioka, Chika Yamashita, Masatoshi Miyamura, Tatsuhiko Mori, Akira Ukimura, Chika Matsumoto, Yasuo Matsumura, Yasushi Kitaura, Tetsuya Hayashi. (2010) Pitavastatin reduces oxidative stress and attenuates intermittent hypoxia-induced left ventricular remodeling in lean mice. Hypertension Research 33:6, 579-586
    CrossRef

  136. 136

    Devin L. Brown, J. Rajiv Bapuraj, Suresh K. Mukherji, Ronald D. Chervin, Maryann Concannon, Joseph I. Helman, Lynda D. Lisabeth. (2010) MRI of the pharynx in ischemic stroke patients with and without obstructive sleep apnea. Sleep Medicine 11:6, 540-544
    CrossRef

  137. 137

    Alexander G. Logan, T. Douglas Bradley. (2010) Sleep Apnea and Cardiovascular Disease. Current Hypertension Reports 12:3, 182-188
    CrossRef

  138. 138

    Amy M. Fowler, Jonathan J. Dutton. (2010) Floppy Eyelid Syndrome as a Subset of Lax Eyelid Conditions: Relationships and Clinical Relevance (an ASOPRS Thesis). Ophthalmic Plastic & Reconstructive Surgery 26:3, 195-204
    CrossRef

  139. 139

    Patricia Sagaspe, Damien Leger, Jacques Taillard, Virginie Bayon, Guillaume Chaumet, Pierre Philip. (2010) Might the Berlin Sleep Questionnaire applied to bed partners be used to screen sleep apneic patients?. Sleep Medicine 11:5, 479-483
    CrossRef

  140. 140

    Jon-Erik C. Holty, Christian Guilleminault. (2010) Surgical Options for the Treatment of Obstructive Sleep Apnea. Medical Clinics of North America 94:3, 479-515
    CrossRef

  141. 141

    Geert Mayer, Dirk Pevernagie. 2010. Nosological Classification and Diagnostic Strategy. , 41-52.
    CrossRef

  142. 142

    Dirk M. Hermann, Claudio L. Bassetti. 2010. Sleep Disturbances after Stroke. , 217-227.
    CrossRef

  143. 143

    Luciano F Drager, Jonathan Jun, Vsevolod Y Polotsky. (2010) Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis. Current Opinion in Endocrinology, Diabetes and Obesity 17:2, 161-165
    CrossRef

  144. 144

    Albert Lecube, Gabriel Sampol, Patricia Lloberes, Odile Romero, Jordi Mesa, Ferran Morell, Rafael Simó. (2010) Asymptomatic Sleep-disordered Breathing in Premenopausal Women Awaiting Bariatric Surgery. Obesity Surgery 20:4, 454-461
    CrossRef

  145. 145

    David Vearrier, Barbara Phillips, Michael I. Greenberg. (2010) Addressing obstructive sleep apnea in the emergency department. The Journal of Emergency Medicine
    CrossRef

  146. 146

    JOHN J SIM, SCOTT A RASGON, STEPHEN F DEROSE. (2010) Review article: Managing sleep apnoea in kidney diseases. Nephrology 15:2, 146-152
    CrossRef

  147. 147

    Luciano F. Drager, Luiz A. Bortolotto, Cristiane Maki-Nunes, Ivani C. Trombetta, Maria Janieire N.N. Alves, Raffael F. Fraga, Carlos E. Negrão, Eduardo M. Krieger, Geraldo Lorenzi-Filho. (2010) The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome. Atherosclerosis 208:2, 490-495
    CrossRef

  148. 148

    Mehmood Butt, Girish Dwivedi, Omer Khair, Gregory Y.H. Lip. (2010) Obstructive sleep apnea and cardiovascular disease. International Journal of Cardiology 139:1, 7-16
    CrossRef

  149. 149

    Gideon Sousa, Bernhard Schlüter, Dirk Buschatz, Thomas Menke, Eckardt Trowitzsch, Werner Andler, Thomas Reinehr. (2010) A comparison of polysomnographic variables between obese adolescents with polycystic ovarian syndrome and healthy, normal-weight and obese adolescents. Sleep and Breathing 14:1, 33-38
    CrossRef

  150. 150

    Herbert Yue, Cheng-Hui Lin, Christian Guilleminault. (2010) Upper airway changes with a mandibular advancement device. Expert Review of Respiratory Medicine 4:1, 25-28
    CrossRef

  151. 151

    Joaquín Durán-Cantolla, Laura Cancelo Díaz, Ainhoa Álvarez Ruiz-Larrinaga. (2010) EPOC y apneas del sueño. Archivos de Bronconeumología 46, 2-10
    CrossRef

  152. 152

    Faisal Khan, Ribhi Hazin, Yuchi Han. (2010) Apneic Disorders Associated with Heart Failure: Pathophysiology and Clinical Management. Southern Medical Journal 103:1, 44-50
    CrossRef

  153. 153

    Claudio Vicini, Iacopo Dallan, Aldo Campanini, Andrea De Vito, Francesca Barbanti, Gianluca Giorgiomarrano, Marcello Bosi, Giuseppe Plazzi, Federica Provini, Elio Lugaresi. (2010) Surgery vs ventilation in adult severe obstructive sleep apnea syndrome. American Journal of Otolaryngology 31:1, 14-20
    CrossRef

  154. 154

    Shirin Shafazand. 2010. Sleep in WomenGender Differences in Health and Disease. , 244-251.
    CrossRef

  155. 155

    PERETZ LAVIE, LENA LAVIE. (2009) Unexpected survival advantage in elderly people with moderate sleep apnoea. Journal of Sleep Research 18:4, 397-403
    CrossRef

  156. 156

    Marc Bonnin-Vilaplana, Adrià Arboix, Olga Parra, Luis García-Eroles, Josep M. Montserrat, Joan Massons. (2009) Sleep-related breathing disorders in acute lacunar stroke. Journal of Neurology 256:12, 2036-2042
    CrossRef

  157. 157

    D. Skowasch, G. Bönner, G. Nickenig. (2009) Obstruktive Schlafapnoe als Risikofaktor der Arteriosklerose. Somnologie - Schlafforschung und Schlafmedizin 13:4, 215-220
    CrossRef

  158. 158

    Ken Monahan, Amy Storfer-Isser, Reena Mehra, Eyal Shahar, Murray Mittleman, Jeff Rottman, Naresh Punjabi, Mark Sanders, Stuart F. Quan, Helaine Resnick, Susan Redline. (2009) Triggering of Nocturnal Arrhythmias by Sleep-Disordered Breathing Events. Journal of the American College of Cardiology 54:19, 1797-1804
    CrossRef

  159. 159

    Andrew D Calvin, Virend K Somers. (2009) Obstructive sleep apnea and cardiovascular disease. Current Opinion in Cardiology 24:6, 516-520
    CrossRef

  160. 160

    J.-P. Laaban, S. Daenen, D. Léger, S. Pascal, V. Bayon, G. Slama, F. Elgrably. (2009) Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients. Diabetes & Metabolism 35:5, 372-377
    CrossRef

  161. 161

    Ian Smith, Toby J Lasserson, Ian Smith. 2009. Pressure modification for improving usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea. .
    CrossRef

  162. 162

    José Nieto Enríquez, Jesús Torres Blanch, Josep Badal Lafulla. (2009) Manifestaciones oculares del síndrome de apnea del sueño. Medicina Clínica 133:15, 594-598
    CrossRef

  163. 163

    C. Holmdahl, I.-L. Schöllin, M. Alton, K. Nilsson. (2009) CPAP treatment in obstructive sleep apnoea: A randomised, controlled trial of follow-up with a focus on patient satisfaction. Sleep Medicine 10:8, 869-874
    CrossRef

  164. 164

    Sanja Jelic, Thierry H. Jemtel. (2009) Sleep-disordered breathing in acute decompensated heart failure. Current Heart Failure Reports 6:3, 169-175
    CrossRef

  165. 165

    Kiran Devulapally, Raymond Pongonis, Rami Khayat. (2009) OSA: the new cardiovascular disease. Heart Failure Reviews 14:3, 155-164
    CrossRef

  166. 166

    Neomi Shah, Francoise Roux. (2009) The Relationship of Obesity and Obstructive Sleep Apnea. Clinics in Chest Medicine 30:3, 455-465
    CrossRef

  167. 167

    JINKWAN KIM, SEUNGGWAN LEE, KWANGHO IN, JEHYEONG KIM, SEHWA YOU, KYUNGHO KANG, JAEJEONG SIM, SANGYEUB LEE, DAEWUI YOON, JUNGBOK LEE, CHOL SHIN. (2009) Increase in serum haptoglobin and apolipoprotein M in patients with obstructive sleep apnoea. Journal of Sleep Research 18:3, 313-320
    CrossRef

  168. 168

    Basheer Khassawneh, Mohammad Ghazzawi, Yousef Khader, Mousa Alomari, Zouhair Amarin, Bashar Shahrour, Mohanad Hammouda. (2009) Symptoms and risk of obstructive sleep apnea in primary care patients in Jordan. Sleep and Breathing 13:3, 227-232
    CrossRef

  169. 169

    Ignacio Cruz-González, Jorge Solis, Thomas J Kiernan, Bryan P Yan, Yat-Yin Lam, Igor F Palacios. (2009) Clinical manifestation and current management of patent foramen ovale. Expert Review of Cardiovascular Therapy 7:8, 1011-1022
    CrossRef

  170. 170

    Vahid Mohsenin, H. Klar Yaggi, Neomi Shah, James Dziura. (2009) The effect of gender on the prevalence of hypertension in obstructive sleep apnea. Sleep Medicine 10:7, 759-762
    CrossRef

  171. 171

    Françoise Stanke-Labesque, Magnus Bäck, Blandine Lefebvre, Renaud Tamisier, Jean-Philippe Baguet, Nathalie Arnol, Patrick Lévy, Jean-Louis Pépin. (2009) Increased urinary leukotriene E4 excretion in obstructive sleep apnea: Effects of obesity and hypoxia. Journal of Allergy and Clinical Immunology 124:2, 364-370.e2
    CrossRef

  172. 172

    Mohsen Sadatsafavi, Carlo A. Marra, Najib T. Ayas, John Stradling, John Fleetham. (2009) Cost-effectiveness of oral appliances in the treatment of obstructive sleep apnoea–hypopnoea. Sleep and Breathing 13:3, 241-252
    CrossRef

  173. 173

    Andrew D. Calvin, Felipe N. Albuquerque, Francisco Lopez-Jimenez, Virend K. Somers. (2009) Obstructive Sleep Apnea, Inflammation, and the Metabolic Syndrome. Metabolic Syndrome and Related Disorders 7:4, 271-277
    CrossRef

  174. 174

    Paolo Castiglioni, Carolina Lombardi. (2009) Cardiovascular regulation and cardiovascular diseases: what can sleep teach us?. Journal of Hypertension 27:8, 1533-1535
    CrossRef

  175. 175

    Kevin J. Finkel, Adam C. Searleman, Heidi Tymkew, Christopher Y. Tanaka, Leif Saager, Elika Safer-Zadeh, Michael Bottros, Jacqueline A. Selvidge, Eric Jacobsohn, Debra Pulley, Stephen Duntley, Colleen Becker, Michael S. Avidan. (2009) Prevalence of undiagnosed obstructive sleep apnea among adult surgical patients in an academic medical center. Sleep Medicine 10:7, 753-758
    CrossRef

  176. 176

    J-P Baguet, G Barone-Rochette, J-L Pépin. (2009) Hypertension and obstructive sleep apnoea syndrome: current perspectives. Journal of Human Hypertension 23:7, 431-443
    CrossRef

  177. 177

    J. Kisucka, A. K. Chauhan, B.-Q. Zhao, I. S. Patten, A. Yesilaltay, M. Krieger, D. D. Wagner. (2009) Elevated levels of soluble P-selectin in mice alter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis. Blood 113:23, 6015-6022
    CrossRef

  178. 178

    F. Mallamaci, D. Leonardis, R. Tripepi, G. Parlongo, C. Catalano, G. Tripepi, V. Castronovo, L. Ferini-Strambi, C. Zoccali. (2009) Sleep Disordered Breathing in Renal Transplant Patients. American Journal of Transplantation 9:6, 1373-1381
    CrossRef

  179. 179

    Soňa Grešová, Zoltán Tomori, Martin Kurpas, Alexander Marossy, Adela Vrbenská, Martin Kundrík, Viliam Donič. (2009) Blood pressure increase detected by ambulatory monitoring correlates with hypoxemia reflecting sleep apnea severity. Central European Journal of Medicine 4:2, 222-232
    CrossRef

  180. 180

    Robert H Fagard. (2009) Dipping pattern of nocturnal blood pressure in patients with hypertension. Expert Review of Cardiovascular Therapy 7:6, 599-605
    CrossRef

  181. 181

    Claire Arnaud, Maurice Dematteis, Jean-Louis Pepin, Jean-Philippe Baguet, Patrick Lévy. (2009) Obstructive sleep apnea, immuno-inflammation, and atherosclerosis. Seminars in Immunopathology 31:1, 113-125
    CrossRef

  182. 182

    Austin Chin Chwan Ng, Saul Benedict Freedman. (2009) Sleep disordered breathing in chronic heart failure. Heart Failure Reviews 14:2, 89-99
    CrossRef

  183. 183

    D. L. Brown, D. Feskanich, B. N. Sanchez, K. M. Rexrode, E. S. Schernhammer, L. D. Lisabeth. (2009) Rotating Night Shift Work and the Risk of Ischemic Stroke. American Journal of Epidemiology 169:11, 1370-1377
    CrossRef

  184. 184

    Jordi Jiménez-Conde, Jaume Roquer. (2009) Los ritmos del ictus isquémico: factores externos que contribuyen a modular el momento de aparición de los eventos. Medicina Clínica 132:17, 671-676
    CrossRef

  185. 185

    Patrick Hanly. (2009) Sleep Disorders and Home Dialysis. Advances in Chronic Kidney Disease 16:3, 179-188
    CrossRef

  186. 186

    Magnus C. Johansson, Peter Eriksson, Mikael Dellborg. (2009) The significance of patent foramen ovale. International Journal of Cardiology 134:1, 17-24
    CrossRef

  187. 187

    M. H. J. DOFF, A. HOEKEMA, G. J. PRUIM, J. H. van der HOEVEN, L. G. M. de BONT, B. STEGENGA. (2009) Effects of a mandibular advancement device on the upper airway morphology: a cephalometric analysis. Journal of Oral Rehabilitation 36:5, 330-337
    CrossRef

  188. 188

    Oded Friedman, Alexander G. Logan. (2009) The Price of Obstructive Sleep Apnea–Hypopnea: Hypertension and Other Ill Effects. American Journal of Hypertension 22:5, 474-483
    CrossRef

  189. 189

    Nishant B Jalandhara, Anil Patel, Rohit R Arora, Priyanka Jalandhara. (2009) Obstructive Sleep Apnea: A Cardiopulmonary Perspective and Medical Therapeutics. American Journal of Therapeutics 16:3, 257-263
    CrossRef

  190. 190

    Shiroh Isono. (2009) Obstructive Sleep Apnea of Obese Adults. Anesthesiology 110:4, 908-921
    CrossRef

  191. 191

    Hans Brunner. (2009) Sleep apnea in stroke patients: hard to diagnose, even harder to treat. Aging Health 5:2, 193-205
    CrossRef

  192. 192

    G. Tsivgoulis, A. V. Alexandrov. (2009) Cerebral autoregulation impairment during wakefulness in obstructive sleep apnea syndrome is a potential mechanism increasing stroke risk. European Journal of Neurology 16:3, 283-284
    CrossRef

  193. 193

    Allan I. Pack, Thorarinn Gislason. (2009) Obstructive Sleep Apnea and Cardiovascular Disease. Progress in Cardiovascular Diseases 51:5, 434-451
    CrossRef

  194. 194

    Luciano F. Drager, Eduardo L. Queiroz, Heno F. Lopes, Pedro R. Genta, Eduardo M. Krieger, Geraldo Lorenzi-Filho. (2009) Obstructive Sleep Apnea Is Highly Prevalent and Correlates With Impaired Glycemic Control in Consecutive Patients With the Metabolic Syndrome. Journal of the CardioMetabolic Syndrome 4:2, 89-95
    CrossRef

  195. 195

    N. Nasr, A. Pavy-Le Traon, M. Czosnyka, M. Tiberge, E. Schmidt, V. Larrue. (2009) Cerebral autoregulation in patients with obstructive sleep apnea syndrome during wakefulness. European Journal of Neurology 16:3, 386-391
    CrossRef

  196. 196

    Patrick Lévy, Jean-Louis Pépin, Claire Arnaud, Jean-Philippe Baguet, Maurice Dematteis, François Mach. (2009) Obstructive Sleep Apnea and Atherosclerosis. Progress in Cardiovascular Diseases 51:5, 400-410
    CrossRef

  197. 197

    István Bernáth, Patrick McNamara, Nóra Szternák, Zoltán Szakács, Péter Köves, Attila Terray-Horváth, Zsuzsanna Vida. (2009) Hyperviscosity as a possible cause of positive acoustic evoked potential findings in patients with sleep apnea: A dual electrophysiological and hemorheological study. Sleep Medicine 10:3, 361-367
    CrossRef

  198. 198

    Amy Atkeson, Susie Yim Yeh, Atul Malhotra, Sanja Jelic. (2009) Endothelial Function in Obstructive Sleep Apnea. Progress in Cardiovascular Diseases 51:5, 351-362
    CrossRef

  199. 199

    Marcel A. Baltzan, Osama Elkholi, Norman Wolkove. (2009) Evidence of interrelated side effects with reduced compliance in patients treated with nasal continuous positive airway pressure. Sleep Medicine 10:2, 198-205
    CrossRef

  200. 200

    Diana C. Dolan, Renata Okonkwo, Florian Gfullner, J. Randall Hansbrough, Richard J. Strobel, Leon Rosenthal. (2009) Longitudinal comparison study of pressure relief (C-Flex™) vs. CPAP in OSA patients. Sleep and Breathing 13:1, 73-77
    CrossRef

  201. 201

    Adrian Aron, Donald Zedalis, John M. Gregg, Francis C. Gwazdauskas, William G. Herbert. (2009) Potential clinical use of cardiopulmonary exercise testing in obstructive sleep apnea hypopnea syndrome. International Journal of Cardiology 132:2, 176-186
    CrossRef

  202. 202

    Javier Navarro-Antolín, Carmen Carmona-Bernal, Verónica Rivero-Valdenebro, José Villar, Francisco Capote, José López-Barneo. (2009) Maxi-K+ Channel β1 Expression in Sleep Apnea Patients and Its Modulation by CPAP Treatment. American Journal of Hypertension 22:2, 197-202
    CrossRef

  203. 203

    Seockhoon Chung, In-Young Yoon, Yoon-Kyung Shin, Chul Hee Lee, Jeong-Whun Kim, Hee Jeong Ahn. (2009) Endothelial dysfunction and inflammatory reactions of elderly and middle-aged men with obstructive sleep apnea syndrome. Sleep and Breathing 13:1, 11-17
    CrossRef

  204. 204

    Fawad Taj, Zarmeneh Aly, Osman Arif, Bhojo Khealani, Mansoor Ahmed. (2009) Risk for sleep apnea syndrome in Pakistan: a cross-sectional survey utilizing the Berlin questionnaire. Sleep and Breathing 13:1, 103-106
    CrossRef

  205. 205

    J. Nanduri, N. Wang, G. Yuan, S. A. Khan, D. Souvannakitti, Y.-J. Peng, G. K. Kumar, J. A. Garcia, N. R. Prabhakar. (2009) Intermittent hypoxia degrades HIF-2  via calpains resulting in oxidative stress: Implications for recurrent apnea-induced morbidities. Proceedings of the National Academy of Sciences 106:4, 1199-1204
    CrossRef

  206. 206

    Masahiko Kato, Taro Adachi, Yuki Koshino, Virend K. Somers. (2009) Obstructive Sleep Apnea and Cardiovascular Disease. Circulation Journal 73:8, 1363-1370
    CrossRef

  207. 207

    Lena Lavie. (2009) Oxidative Stress—A Unifying Paradigm in Obstructive Sleep Apnea and Comorbidities. Progress in Cardiovascular Diseases 51:4, 303-312
    CrossRef

  208. 208

    Donald M. Sesso, Robert W. Riley, Nelson B. Powell. 2009. Rationale and indications for surgical treatment. , 80-84.
    CrossRef

  209. 209

    T Douglas Bradley, John S Floras. (2009) Obstructive sleep apnoea and its cardiovascular consequences. The Lancet 373:9657, 82-93
    CrossRef

  210. 210

    Glen E. Foster, Patrick J. Hanly, Michele Ostrowski, Marc J. Poulin. (2009) Ventilatory and cerebrovascular responses to hypercapnia in patients with obstructive sleep apnoea: Effect of CPAP therapy. Respiratory Physiology & Neurobiology 165:1, 73-81
    CrossRef

  211. 211

    Yongxia Li, Virasakdi Chongsuvivatwong, Alan Geater, Ao Liu. (2009) Exhaled breath condensate cytokine level as a diagnostic tool for obstructive sleep apnea syndrome. Sleep Medicine 10:1, 95-103
    CrossRef

  212. 212

    Mark H. Sanders, Patrick J. Strollo, Charles W. Atwood, Ronald A. Stiller, Christopher P. O'Donnell. 2009. Positive Airway Pressure in the Treatment of Sleep Apnea-Hypopnea. , 340-360.
    CrossRef

  213. 213

    Karin Lundkvist, Anna Januszkiewicz, Danielle Friberg. (2009) Uvulopalatopharyngoplasty in 158 OSAS patients failing non-surgical treatment. Acta Oto-laryngologica 129:11, 1280-1286
    CrossRef

  214. 214

    Christian Guilleminault, Shanon Takaoka. 2009. Signs and symptoms of obstructive sleep apnea and upper airway resistance syndrome. , 3-10.
    CrossRef

  215. 215

    Raffaele Scala, Peter M. Turkington, Peter Wanklyn, John Bamford, Mark W. Elliott. (2009) Acceptance, effectiveness and safety of continuous positive airway pressure in acute stroke: A pilot study. Respiratory Medicine 103:1, 59-66
    CrossRef

  216. 216

    Atul Malhotra, Joseph Loscalzo. (2009) Sleep and Cardiovascular Disease: An Overview. Progress in Cardiovascular Diseases 51:4, 279-284
    CrossRef

  217. 217

    Christian Guilleminault, Michael Zupancic. 2009. Obstructive Sleep Apnea Syndrome. , 319-339.
    CrossRef

  218. 218

    Sudhansu Chokroverty, Pasquale Montagna. 2009. Sleep, Breathing, and Neurologic Disorders. , 436-498.
    CrossRef

  219. 219

    Naohide Kondo, Yasuhiro Ito, Makoto Kawai, Junichiro Suzuki, Hirotake Tsuji, Suguru Nishida, Takeshi Yasuda, Gen Sobue. (2009) Obstructive Sleep Apnea Syndrome (OSAS) Presenting as Cerebral Venous Thrombosis. Internal Medicine 48:20, 1837-1840
    CrossRef

  220. 220

    Donald M. Sesso, Robert W. Riley, Nelson B. Powell. 2009. Maxillofacial surgical techniques for hypopharyngeal obstruction in obstructive sleep apnea. , 326-333.
    CrossRef

  221. 221

    Liliana Sollazzi, Cristina Modesti, Francesca Vitale, Teresa Sacco, Pierpaolo Ciocchetti, Anna Sara Idra, Roberto Maria Tacchino, Valter Perilli. (2009) Preinductive use of clonidine and ketamine improves recovery and reduces postoperative pain after bariatric surgery. Surgery for Obesity and Related Diseases 5:1, 67-71
    CrossRef

  222. 222

    Nanna Browaldh, Agneta Markström, Danielle Friberg. (2009) Elective tracheostomy is an alternative treatment in patients with severe obstructive sleep apnoea syndrome and CPAP failure. Acta Oto-laryngologica 129:10, 1121-1126
    CrossRef

  223. 223

    Andrew D Calvin, Virend K Somers. (2008) Obstructive sleep apnea and risk of stroke: time for a trial. Nature Clinical Practice Cardiovascular Medicine 6:2, 90-91
    CrossRef

  224. 224

    Giuseppe Micieli, Anna Cavallini. (2008) The autonomic nervous system and ischemic stroke: a reciprocal interdependence. Clinical Autonomic Research 18:6, 308-317
    CrossRef

  225. 225

    Chol Shin, Jin K. Kim, Je H. Kim, Ki H. Jung, Kyung J. Cho, Chang K. Lee, Seung G. Lee. (2008) Increased cell-free DNA concentrations in patients with obstructive sleep apnea. Psychiatry and Clinical Neurosciences 62:6, 721-727
    CrossRef

  226. 226

    Robert H. Fagard, Lutgarde Thijs, Jan A. Staessen, Denis L. Clement, Marc L. De Buyzere, Dirk A. De Bacquer. (2008) Prognostic significance of ambulatory blood pressure in hypertensive patients with history of cardiovascular disease. Blood Pressure Monitoring 13:6, 325-332
    CrossRef

  227. 227

    Patrick Hanly. (2008) Sleep disorders and end-stage renal disease. Current Opinion in Pulmonary Medicine 14:6, 543-550
    CrossRef

  228. 228

    Sharon A. Chung, Hongbo Yuan, Frances Chung. (2008) A Systemic Review of Obstructive Sleep Apnea and Its Implications for Anesthesiologists. Anesthesia & Analgesia 107:5, 1543-1563
    CrossRef

  229. 229

    Olaf Oldenburg, Barbara Lamp, Klaus Freivogel, Thomas Bitter, Christoph Langer, Dieter Horstkotte. (2008) Low night-to-night variability of sleep disordered breathing in patients with stable congestive heart failure. Clinical Research in Cardiology 97:11, 836-842
    CrossRef

  230. 230

    Juan Fernando Masa Jiménez, Jaime Corral Peñafiel, Estefanía García Ledesma, José María Montserrat. (2008) 2006: Año de la Apnea del Sueño. Análisis de las publicaciones en Archivos de Bronconeumología. Archivos de Bronconeumología 44:11, 611-620
    CrossRef

  231. 231

    E. A. Waller, R. E. Bendel, J. Kaplan. (2008) Sleep Disorders and the Eye. Mayo Clinic Proceedings 83:11, 1251-1261
    CrossRef

  232. 232

    Sanja Jelic, Thierry H. Le Jemtel. (2008) Inflammation, Oxidative Stress, and the Vascular Endothelium in Obstructive Sleep Apnea. Trends in Cardiovascular Medicine 18:7, 253-260
    CrossRef

  233. 233

    Meredith Broderick, Christian Guilleminault. (2008) Neurological Aspects of Obstructive Sleep Apnea. Annals of the New York Academy of Sciences 1142:1, 44-57
    CrossRef

  234. 234

    CAROLINA LOMBARDI, GIANFRANCO PARATI, PIETRO CORTELLI, FEDERICA PROVINI, ROBERTO VETRUGNO, GIUSEPPE PLAZZI, LUCA VIGNATELLI, MARCO DI RIENZO, ELIO LUGARESI, GIUSEPPE MANCIA, PASQUALE MONTAGNA, PAOLO CASTIGLIONI. (2008) Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders. Journal of Sleep Research 17:3, 263-270
    CrossRef

  235. 235

    Mark Eric Dyken, Kyoung Bin Im. (2008) Sleep-Disordered Breathing and Stroke. Sleep Medicine Clinics 3:3, 361-376
    CrossRef

  236. 236

    José Biller. (2008) The role of antiplatelet therapy in the management of ischemic stroke: implementation of guidelines in current practice. Neurological Research 30:7, 669-677
    CrossRef

  237. 237

    Ahmet Ursavaş, Mehmet Karadag, Arzu Yilmaztepe Oral, Ezgi Demirdogen, Haluk Barbaros Oral, Ercüment Ege. (2008) Association between serum neopterin, obesity and daytime sleepiness in patients with obstructive sleep apnea. Respiratory Medicine 102:8, 1193-1197
    CrossRef

  238. 238

    Virend K. Somers, David P. White, Raouf Amin, William T. Abraham, Fernando Costa, Antonio Culebras, Stephen Daniels, John S. Floras, Carl E. Hunt, Lyle J. Olson, Thomas G. Pickering, Richard Russell, Mary Woo, Terry Young. (2008) Sleep Apnea and Cardiovascular Disease. Journal of the American College of Cardiology 52:8, 686-717
    CrossRef

  239. 239

    Rainer Dziewas, Benjamin Hopmann, Marius Humpert, Martin Ritter, Ralf Dittrich, Wolf R. Schäbitz, E. Bernd Ringelstein, Darius G. Nabavi, Peter Young. (2008) Positional sleep apnea in patients with ischemic stroke. Neurological Research 30:6, 645-648
    CrossRef

  240. 240

    Fatima H. Sert Kuniyoshi, Arturo Garcia-Touchard, Apoor S. Gami, Abel Romero-Corral, Christelle van der Walt, Snigdha Pusalavidyasagar, Tomas Kara, Sean M. Caples, Gregg S. Pressman, Elisardo C. Vasquez, Francisco Lopez-Jimenez, Virend K. Somers. (2008) Day–Night Variation of Acute Myocardial Infarction in Obstructive Sleep Apnea. Journal of the American College of Cardiology 52:5, 343-346
    CrossRef

  241. 241

    Wolfram Grimm. (2008) Arrhythmias in patients with obstructive sleep apnea. Sleep Medicine 9:5, 471-472
    CrossRef

  242. 242

    M. Riedl, A. Suhrbier, H. Malberg, T. Penzel, G. Bretthauer, J. Kurths, N. Wessel. (2008) Modeling the cardiovascular system using a nonlinear additive autoregressive model with exogenous input. Physical Review E 78:1,
    CrossRef

  243. 243

    KRIT JONGNARANGSIN, AMAN CHUGH, ERIC GOOD, SIDDHARTH MUKERJI, SUJOYA DEY, THOMAS CRAWFORD, JEAN F. SARRAZIN, MICHAEL KUHNE, NAGIB CHALFOUN, DARRYL WELLS, WARANGKNA BOONYAPISIT, FRANK PELOSI, Jr, FRANK BOGUN, FRED MORADY, HAKAN ORAL. (2008) Body Mass Index, Obstructive Sleep Apnea, and Outcomes of Catheter Ablation of Atrial Fibrillation. Journal of Cardiovascular Electrophysiology 19:7, 668-672
    CrossRef

  244. 244

    A. G. P. de Sousa, C. Cercato, M. C. Mancini, A. Halpern. (2008) Obesity and obstructive sleep apnea-hypopnea syndrome. Obesity Reviews 9:4, 340-354
    CrossRef

  245. 245

    Bernabé Jurado Gámez, Alejandro Martín-Malo, Mari Carmen Fernández Marín, Alberto Rodríguez-Benot, Natalia Pascual, Luis Muñoz Cabrera, Pedro Aljama. (2008) Trastornos del sueño en pacientes en lista de espera de trasplante renal. Archivos de Bronconeumología 44:7, 371-375
    CrossRef

  246. 246

    A D Protogerou, J-P Laaban, S Czernichow, C Kostopoulos, J Lekakis, M E Safar, J Blacher. (2008) Structural and functional arterial properties in patients with obstructive sleep apnoea syndrome and cardiovascular comorbidities. Journal of Human Hypertension 22:6, 415-422
    CrossRef

  247. 247

    Joji Ishikawa, Satoshi Hoshide, Kazuo Eguchi, Shizukiyo Ishikawa, Thomas G Pickering, Kazuyuki Shimada, Kazuomi Kario. (2008) Increased low-grade inflammation and plasminogen-activator inhibitor-1 level in nondippers with sleep apnea syndrome. Journal of Hypertension 26:6, 1181-1187
    CrossRef

  248. 248

    Won Lee, Swamy Nagubadi, Meir H Kryger, Babak Mokhlesi. (2008) Epidemiology of obstructive sleep apnea: a population-based perspective. Expert Review of Respiratory Medicine 2:3, 349-364
    CrossRef

  249. 249

    G Dwivedi, O Khair, G Y H Lip. (2008) Obstructive sleep apnoea and metabolic syndrome: two sides of the same coin?. Journal of Human Hypertension 22:6, 377-379
    CrossRef

  250. 250

    Kevin Martin, Michael Stanchina, Nicola Kouttab, Elizabeth O. Harrington, Sharon Rounds. (2008) Circulating Endothelial Cells and Endothelial Progenitor Cells in Obstructive Sleep Apnea. Lung 186:3, 145-150
    CrossRef

  251. 251

    NIELS PETRI, PALLE SVANHOLT, BENI SOLOW, GORDON WILDSCHIØDTZ, PER WINKEL. (2008) Mandibular advancement appliance for obstructive sleep apnoea: results of a randomised placebo controlled trial using parallel group design. Journal of Sleep Research 17:2, 221-229
    CrossRef

  252. 252

    Helaine E. Resnick, Barbara Phillips. (2008) Documentation of Sleep Apnea in Nursing Homes: United States 2004. Journal of the American Medical Directors Association 9:4, 260-264
    CrossRef

  253. 253

    Marina Mauro, Valerie Taylor, Sean Wharton, Arya M. Sharma. (2008) Barriers to obesity treatment. European Journal of Internal Medicine 19:3, 173-180
    CrossRef

  254. 254

    Akram Khan, Faisal Latif, Beau Hawkins, Maroun Tawk, Chittur A. Sivaram, Gary Kinasewitz. (2008) Effects of obstructive sleep apnea treatment on left atrial volume and left atrial volume index. Sleep and Breathing 12:2, 141-147
    CrossRef

  255. 255

    Miguel A. Arias, Sonia Bartolomé, Luis Rodríguez-Padial. (2008) Obesity, Cardiovascular Disease and Obstructive Sleep Apnea. The American Journal of Medicine 121:5, e13
    CrossRef

  256. 256

    Carl W. Bazil. (2008) Nocturnal seizures and the effects of anticonvulsants on sleep. Current Neurology and Neuroscience Reports 8:2, 149-154
    CrossRef

  257. 257

    Jordan S. Querido, Jesse B. Godwin, A. William Sheel. (2008) Intermittent hypoxia reduces cerebrovascular sensitivity to isocapnic hypoxia in humans. Respiratory Physiology & Neurobiology 161:1, 1-9
    CrossRef

  258. 258

    Monique A. Ford, Thomas G. Allison, Amir Lerman. (2008) New approaches to the concept of primary prevention of atherosclerosis. Current Treatment Options in Cardiovascular Medicine 10:1, 73-82
    CrossRef

  259. 259

    Ariel Tarasiuk, Sari Greenberg-Dotan, Tzahit Simon-Tuval, Arie Oksenberg, Haim Reuveni. (2008) The Effect of Obstructive Sleep Apnea on Morbidity and Health Care Utilization of Middle-Aged and Older Adults. Journal of the American Geriatrics Society 56:2, 247-254
    CrossRef

  260. 260

    Lena Lavie. (2008) Intermittent hypoxia: the culprit of oxidative stress, vascular inflammation and dyslipidemia in obstructive sleep apnea. Expert Review of Respiratory Medicine 2:1, 75-84
    CrossRef

  261. 261

    Kannan Ramar, Christian Guilleminault. (2008) Cardiovascular complications of obstructive sleep apnea. Expert Review of Respiratory Medicine 2:1, 63-74
    CrossRef

  262. 262

    Lars Lüthje, Stefan Andreas. (2008) Obstructive sleep apnea and coronary artery disease. Sleep Medicine Reviews 12:1, 19-31
    CrossRef

  263. 263

    Bernabé Jurado Gámez, Alejandro Martín-Malo, Mari Carmen Fernández Marín, Luis Muñoz, Pedro Aljama. (2008) Valor del análisis cardiorrespiratorio en el diagnóstico de los trastornos respiratorios del sueño en pacientes con insuficiencia renal crónica. Medicina Clínica 130:2, 47-50
    CrossRef

  264. 264

    Jean K. Fleischman, Renuka Ananthamoorthy, Harly Greenberg, Carolyn Harvey, Joseph P. Merlino. (2008) An unexplained death in the psychiatric emergency room: a case of undiagnosed obstructive sleep apnea?. General Hospital Psychiatry 30:1, 83-86
    CrossRef

  265. 265

    Akiko NODA, Seiichi NAKATA, Hiroshi FUKATSU, Yoshinari YASUDA, Etsuko MIYAO, Seiko MIYATA, Fumihiko YASUMA, Toyoaki MUROHARA, Mitsuhiro YOKOTA, Yasuo KOIKE. (2008) Aortic Pressure Augmentation as a Marker of Cardiovascular Risk in Obstructive Sleep Apnea Syndrome. Hypertension Research 31:6, 1109-1114
    CrossRef

  266. 266

    Xinjun Li, Kristina Sundquist, Jan Sundquist. (2008) Socioeconomic status and occupation as risk factors for obstructive sleep apnea in Sweden: A population-based study. Sleep Medicine 9:2, 129-136
    CrossRef

  267. 267

    Kohei NAGATA, Naohiko OSADA, Minako SHIMAZAKI, Keisuke KIDA, Kihei YONEYAMA, Ayako TSUCHIYA, Takashi YASUDA, Kenjiro KIMURA. (2008) Diurnal Blood Pressure Variation in Patients with Sleep Apnea Syndrome. Hypertension Research 31:2, 185-191
    CrossRef

  268. 268

    Amy S. Jordan, David P. White. (2008) Pharyngeal motor control and the pathogenesis of obstructive sleep apnea. Respiratory Physiology & Neurobiology 160:1, 1-7
    CrossRef

  269. 269

    Kunitoshi ISEKI, Kazuyo TOHYAMA, Tsuyoshi MATSUMOTO, Hiroshi NAKAMURA. (2008) High Prevalence of Chronic Kidney Disease among Patients with Sleep Related Breathing Disorder (SRBD). Hypertension Research 31:2, 249-255
    CrossRef

  270. 270

    Nir Peled, Micha Kassirer, Mordechai R. Kramer, Ori Rogowski, Dekel Shlomi, Ben Fox, Abraham S. Berliner, David Shitrit. (2008) Increased erythrocyte adhesiveness and aggregation in obstructive sleep apnea syndrome. Thrombosis Research 121:5, 631-636
    CrossRef

  271. 271

    Lena Lavie, Larissa Dyugovskaya, Andrey Polyakov. (2008) Biology of peripheral blood cells in obstructive sleep apnea – the tip of the iceberg. Archives Of Physiology And Biochemistry 114:4, 244-254
    CrossRef

  272. 272

    Neil J. Douglas. 2008. Obstructive Sleep Apnea. , 919-927.
    CrossRef

  273. 273

    Renzhe CUI, Takeshi TANIGAWA, Susumu SAKURAI, Kazumasa YAMAGISHI, Hironori IMANO, Tetsuya OHIRA, Akihiko KITAMURA, Shinichi SATO, Takashi SHIMAMOTO, Hiroyasu ISO. (2008) Associations of Sleep-Disordered Breathing with Excessive Daytime Sleepiness and Blood Pressure in Japanese Women. Hypertension Research 31:3, 501-506
    CrossRef

  274. 274

    S.M. Sadikot. (2007) An overview: Obstructive Sleep Apnea and the Metabolic Syndrome: Should “X” be changed to “Zzz…Zzzz….Zzzzzzzzz….Zzz”?. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 1:4, 287-302
    CrossRef

  275. 275

    Julio A. Barcena, James C. Fang. (2007) Diagnosis and treatment of sleep apnea in heart disease. Current Treatment Options in Cardiovascular Medicine 9:6, 501-509
    CrossRef

  276. 276

    Susmita Chowdhuri, Errol D. Crook, Herman A. Taylor, M Safwan Badr. (2007) Cardiovascular Complications of Respiratory Diseases. The American Journal of the Medical Sciences 334:5, 361-380
    CrossRef

  277. 277

    Wilbert S. Aronow. (2007) Cardiovascular Manifestations Seen in Obstructive Sleep Apnea. Comprehensive Therapy 33:2, 82-86
    CrossRef

  278. 278

    Harry Teichtahl, David Wang. (2007) Sleep-disordered breathing with chronic opioid use. Expert Opinion on Drug Safety 6:6, 641-649
    CrossRef

  279. 279

    Oscar Bernal-Pacheco, Gustavo C. Román. (2007) Environmental vascular risk factors: New perspectives for stroke prevention. Journal of the Neurological Sciences 262:1-2, 60-70
    CrossRef

  280. 280

    K Iseki, K Kohagura. (2007) Anemia as a risk factor for chronic kidney disease. Kidney International 72, S4-S9
    CrossRef

  281. 281

    John J. Sim, Scott A. Rasgon, Stephen F. Derose. (2007) Sleep Apnea and Hypertension: Prevalence in Chronic Kidney Disease. The Journal of Clinical Hypertension 9:11, 837-341
    CrossRef

  282. 282

    Marco Antonio Cardoso Machado, Ligia Juliano, Marcel Taga, Luciane Bizari Coin Carvalho, Lucila Bizari Fernandes Prado, Gilmar Fernandes Prado. (2007) Titratable mandibular repositioner appliances for obstructive sleep apnea syndrome: are they an option?. Sleep and Breathing 11:4, 225-231
    CrossRef

  283. 283

    Kin W. TO, Wing C. CHAN, Kah L. CHOO, Wai K. LAM, Kwan K. WONG, David S. HUI. (2007) A randomized cross-over study of auto-continuous positive airway pressure versus fixed-continuous positive airway pressure in patients with obstructive sleep apnoea. Respirology 0:0, 071023220449013-???
    CrossRef

  284. 284

    J. Esteban Varela, Marcelo W. Hinojosa, Ninh T. Nguyen. (2007) Resolution of Obstructive Sleep Apnea after Laparoscopic Gastric Bypass. Obesity Surgery 17:10, 1279-1282
    CrossRef

  285. 285

    Ángel Ortega González, Raúl Hidalgo Carvajal. (2007) ¿Hacia una aproximación diagnóstica al síndrome de apneas-hipopneas durante el sueño desde sus consecuencias cardiovasculares?. Medicina Clínica 129:13, 504-505
    CrossRef

  286. 286

    Riccardo Stoohs, J. Janicki, W. Hohenhorst. (2007) Obstruktives Schlafapnoesyndrom und Upper Airway Resistance Syndrom. HNO 55:10, 792-797
    CrossRef

  287. 287

    Pushkar ARGEKAR, Valerie GRIFFIN, David LITAKER, Mahboob RAHMAN. (2007) Sleep apnea in hemodialysis patients: Risk factors and effect on survival. Hemodialysis International 11:4, 435-441
    CrossRef

  288. 288

    M. J. Alberts, B. Ovbiagele. (2007) Current strategies for ischemic stroke prevention: role of multimodal combination therapies. Journal of Neurology 254:10, 1414-1426
    CrossRef

  289. 289

    Jennifer L. Martin, Constance H. Fung. (2007) Quality Indicators for the Care of Sleep Disorders in Vulnerable Elders. Journal of the American Geriatrics Society 55, S424-S430
    CrossRef

  290. 290

    R. Weber, H.C. Diener, M. Grond. (2007) Aktuelle Aspekte der Sekundärprophylaxe des ischämischen Schlaganfalls. Der Nervenarzt 78:10, 1138-1146
    CrossRef

  291. 291

    MIGUEL A. ARIAS, ANA M. SÁNCHEZ. (2007) Obstructive Sleep Apnea and its Relationship to Cardiac Arrhythmias. Journal of Cardiovascular Electrophysiology 18:9, 1006-1014
    CrossRef

  292. 292

    Nir Peled, Micha Kassirer, David Shitrit, Yivgeny Kogan, Dekel Shlomi, Abraham Shlomo Berliner, Mordechai Reuven Kramer. (2007) The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respiratory Medicine 101:8, 1696-1701
    CrossRef

  293. 293

    Nirav P. Patel, Ilene Rosen. (2007) Sleep Apnea and Cardiovascular Disease. Clinical Pulmonary Medicine 14:4, 225-231
    CrossRef

  294. 294

    Aarnoud Hoekema, Frist de Vries, Kees Heydenrijk, Boudewijn Stegenga. (2007) Implant-retained oral appliances: a novel treatment for edentulous patients with obstructive sleep apnea?hypopnea syndrome. Clinical Oral Implants Research 18:3, 383-387
    CrossRef

  295. 295

    Peter Y. Liu, Ian D. Caterson, Ronald R. Grunstein, David J. Handelsman. (2007) Androgens, Obesity, and Sleep-Disordered Breathing in Men. Endocrinology & Metabolism Clinics of North America 36:2, 349-363
    CrossRef

  296. 296

    Vivek Jain. (2007) Clinical Perspective of Obstructive Sleep Apnea–Induced Cardiovascular Complications. Antioxidants & Redox Signaling 9:6, 701-710
    CrossRef

  297. 297

    Akinori Nakata, Masaya Takahashi, Tomoko Ikeda, Takashi Haratani, Minoru Hojou, Shunichi Araki. (2007) Perceived job stress and sleep-related breathing disturbance in Japanese male workers. Social Science & Medicine 64:12, 2520-2532
    CrossRef

  298. 298

    Jordi Jiménez-Conde, Angel Ois, Ana Rodríguez-Campello, Meritxell Gomis, Jaume Roquer. (2007) Does sleep protect against ischemic stroke? less frequent ischemic strokes but more severe ones. Journal of Neurology 254:6, 782-788
    CrossRef

  299. 299

    P. Keßler, F. Ruberg, H. Obbarius, H. Iro, F. W. Neukam. (2007) Chirurgische Behandlungsmöglichkeiten der obstruktiven Schlafapnoe. Mund-, Kiefer- und Gesichtschirurgie 11:2, 81-88
    CrossRef

  300. 300

    Thierry H. Le Jemtel, Sanja Jelic. (2007) Seek and Treat Obstructive Sleep Apnea in Heart Failure. Journal of the American College of Cardiology 49:15, 1632-1633
    CrossRef

  301. 301

    Kristina Bengtsson Boström, Jan Hedner, Olle Melander, Ludger Grote, Bo Gullberg, Lennart Råstam, Leif Groop, Ulf Lindblad. (2007) Interaction between the angiotensin-converting enzyme gene insertion/deletion polymorphism and obstructive sleep apnoea as a mechanism for hypertension. Journal of Hypertension 25:4, 779-783
    CrossRef

  302. 302

    Juan Fernando Masa Jiménez, Ferran Barbé Illa, Francisco Capote Gil, Eusebio Chiner Vives, Josefa Díaz De Atauri, Joaquín Durán Cantolla, Salvador López Ortiz, José María Marín Trigo, José María Montserrat Canal, Manuela Rubio González, Joaquín Terán Santos, Carlos Zamarrón Sanz. (2007) Recursos y demoras en el diagnóstico del síndrome de apneas-hipopneas durante el sueño (SAHS). Archivos de Bronconeumología 43:4, 188-198
    CrossRef

  303. 303

    Sandrine H. Launois, Jean-Louis Pépin, Patrick Lévy. (2007) Sleep apnea in the elderly: A specific entity?. Sleep Medicine Reviews 11:2, 87-97
    CrossRef

  304. 304

    Miguel A. Arias, Francisco García-Río, Alberto Alonso-Fernández, Ana M. Sánchez. (2007) Síndromes de apneas-hipopneas durante el sueño e insuficiencia cardiaca. Revista Española de Cardiología 60:4, 415-427
    CrossRef

  305. 305

    Eberhard RITZ, Ralf DIKOW, Marie-Luise GROSS. (2007) Dialysis, cardiovascular disease, and the future. Hemodialysis International 11:s1, S2-S11
    CrossRef

  306. 306

    Juan Fernando Masa Jiménez, Ferran Barbé Illa, Francisco Capote Gil, Eusebio Chiner Vives, Josefa Díaz de Ataur, Joaquín Durán Cantoll, Salvador López Ortiz, José María Marín Trigo, José María Montserrat Canal, Manuela Rubio González, Joaquín Terán Santos, Carlos Zamarrón Sanz, for the Working Group. (2007) Resources and Delays in the Diagnosis of Sleep Apnea-Hypopnea Syndrome. Archivos de Bronconeumología (English Edition) 43:4, 188-198
    CrossRef

  307. 307

    Timothy J. Barreiro, David J. Gemmel. (2007) Noninvasive Ventilation. Critical Care Clinics 23:2, 201-222
    CrossRef

  308. 308

    Joachim H. Ficker. (2007) Neue Methoden der nasalen Überdrucktherapie bei der Schlafapnoe. Der Pneumologe 4:2, 104-111
    CrossRef

  309. 309

    Antonio Culebras. (2007) Cerebrovascular disease and the pathophysiology of obstructive sleep apnea. Current Neurology and Neuroscience Reports 7:2, 173-179
    CrossRef

  310. 310

    William C. Orr. (2007) Sleep-related gastroesophageal reflux: Clinical and physiologic consequences. Current GERD Reports 1:1, 59-64
    CrossRef

  311. 311

    Patrick Hanly. (2007) Sleep Disorders and End-Stage Renal Disease. Sleep Medicine Clinics 2:1, 59-66
    CrossRef

  312. 312

    PERETZ LAVIE, PAULA HERER, LENA LAVIE. (2007) Mortality risk factors in sleep apnoea: a matched case?control study. Journal of Sleep Research 16:1, 128-134
    CrossRef

  313. 313

    G.L. Moneta. (2007) Obstructive Sleep Apnea as a Risk Factor for Stroke and Death. Yearbook of Vascular Surgery 2007, 86-87
    CrossRef

  314. 314

    Luenda E. Charles, Cecil M. Burchfiel, Desta Fekedulegn, Michael E. Andrew, John M. Violanti, Bryan Vila. (2007) Obesity and sleep: the Buffalo Police health study. Policing: An International Journal of Police Strategies & Management 30:2, 203-214
    CrossRef

  315. 315

    B.A. Phillips. (2007) Obstructive Sleep Apnea as a Risk Factor for Stroke and Death. Yearbook of Pulmonary Disease 2007, 247-249
    CrossRef

  316. 316

    B. Nolan. (2007) Obstructive Sleep Apnea as a Risk Factor for Stroke and Death. Yearbook of Neurology and Neurosurgery 2007, 152-154
    CrossRef

  317. 317

    B.A. Phillips. (2007) Increased Carotid Intima-Media Thickness and Serum Inflammatory Markers in Obstructive Sleep Apnea. Yearbook of Pulmonary Disease 2007, 244-245
    CrossRef

  318. 318

    Rainer Dziewas, Martin Ritter, Nesrin Usta, Matthias Boentert, Hyon Hor, Ralf Dittrich, Wolf R. Schäbitz, E. Bernd Ringelstein, Peter Young. (2007) Atherosclerosis and Obstructive Sleep Apnea in Patients with Ischemic Stroke. Cerebrovascular Diseases 24:1, 122-126
    CrossRef

  319. 319

    Luenda E. Charles, Cecil M. Burchfiel, Desta Fekedulegn, Bryan Vila, Tara A. Hartley, James Slaven, Anna Mnatsakanova, John M. Violanti. (2007) Shift work and sleep: the Buffalo Police health study. Policing: An International Journal of Police Strategies & Management 30:2, 215-227
    CrossRef

  320. 320

    Johanna Dahlqvist, Åke Dahlqvist, Johanna Dahlqvist, Åke Dahlqvist, Marie Marklund, Diana Berggren, Hans Stenlund, Karl A. Franklin. (2007) Physical findings in the upper airways related to obstructive sleep apnea in men and women. Acta Oto-laryngologica 127:6, 623-630
    CrossRef

  321. 321

    Flavia B. Consens, Ronald D. Chervin. 2007. Sleep Disorders. , 1267-1283.
    CrossRef

  322. 322

    Kazuomi Kario. (2007) Hypertensive heart disease and sleep apnea syndrome in the elderly. Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 44:1, 35-38
    CrossRef

  323. 323

    B.A. Phillips. (2007) Obstructive Sleep Apnea as a Risk Factor for Stroke and Death. Yearbook of Medicine 2007, 288-290
    CrossRef

  324. 324

    Jun-ichi Suzuki. (2007) Folia Pharmacologica Japonica 129:6, 427-431
    CrossRef

  325. 325

    B.A. Phillips. (2007) Obstructive Sleep Apnea Syndrome Affects Left Ventricular Diastolic Function: Effects of Nasal Continuous Positive Airway Pressure in Men. Yearbook of Pulmonary Disease 2007, 252-253
    CrossRef

  326. 326

    B.A. Phillips. (2007) Effect of Continuous Positive Airway Pressure Versus Supplemental Oxygen on Sleep Quality in Obstructive Sleep Apnea: A Placebo-CPAP-Controlled Study. Yearbook of Pulmonary Disease 2007, 280-283
    CrossRef

  327. 327

    Charlie K. Lan, Mary W. Rose. (2006) Perioperative Management of Obstructive Sleep Apnea. Sleep Medicine Clinics 1:4, 541-548
    CrossRef

  328. 328

    Murtuza M Ahmed, Richard J Schwab. (2006) Upper airway imaging in obstructive sleep apnea. Current Opinion in Pulmonary Medicine 12:6, 397-401
    CrossRef

  329. 329

    J.-C. Meurice. (2006) Le syndrome d’apnées obstructives du sommeil : des troubles métaboliques aux complications cardio-vasculaires. Revue des Maladies Respiratoires 23:5, 143-150
    CrossRef

  330. 330

    David S.C. Hui. (2006) Obstructive sleep apnoea and stroke. Respirology 11:6, 678-680
    CrossRef

  331. 331

    (2006) Heart Failure with Preserved Ejection Fraction. New England Journal of Medicine 355:17, 1828-1831
    Full Text

  332. 332

    Claude Lenfant. (2006) The interdependence of sleep and health—a commentary. Metabolism 55, S50-S53
    CrossRef

  333. 333

    Carolina Q. See, Edward Mensah, Christopher O. Olopade. (2006) Obesity, Ethnicity, and Sleep-Disordered Breathing: Medical and Health Policy Implications. Clinics in Chest Medicine 27:3, 521-533
    CrossRef

  334. 334

    Craig A Hukins. (2006) Obstructive sleep apnea ? management update. Neuropsychiatric Disease and Treatment 2:3, 309-326
    CrossRef

  335. 335

    Natalie Hartenbaum, Nancy Collop, Ilene M. Rosen, Barbara Phillips, Charles F. P. George, James A. Rowley, Neil Freedman, Terri E. Weaver, Indira Gurubhagavatula, Kingman Strohl, Howard M. Leaman, Gary L. Moffitt, Mark R. Rosekind. (2006) Sleep Apnea and Commercial Motor Vehicle Operators:. Journal of Occupational and Environmental Medicine 48:Supplement, S4-S37
    CrossRef

  336. 336

    Victoria A. Catenacci. (2006) Clinical Case Report. Obesity Management 2:4, 154-156
    CrossRef

  337. 337

    Ronald R. Grunstein. (2006) Syndrome Zzzzzzzzz: the overlap between snoring, sleep apnea, and metabolic syndrome. Drug Development Research 67:7, 616-618
    CrossRef

  338. 338

    Antonio Culebras. (2006) Are patients with obstructive sleep apnea at an increased risk of stroke or death?. Nature Clinical Practice Neurology 2:6, 306-307
    CrossRef

  339. 339

    Steven R. Schuster, Maher Tabba, Pradeep Sahota. (2006) Relationship Between the Cardiometabolic Syndrome and Obstructive Sleep Apnea. Journal of the CardioMetabolic Syndrome 1:3, 204-208
    CrossRef

  340. 340

    Chris D. Meletis, Nieske Zabriskie. (2006) To Sleep, Perchance to Breathe: Sleep Apnea, Snoring, and Sleep-Disordered Breathing. Alternative and Complementary Therapies 12:3, 113-120
    CrossRef

  341. 341

    William C. Orr. (2006) Reflux events and sleep: Are we vulnerable?. Current Gastroenterology Reports 8:3, 202-207
    CrossRef

  342. 342

    John M. Dopp, Barbara J. Morgan. (2006) Cardiovascular Consequences of Sleep-disordered Breathing. Journal of Cardiopulmonary Rehabilitation 26:3, 123-130
    CrossRef

  343. 343

    (2006) Sleep Apnea and Heart Disease. New England Journal of Medicine 354:10, 1086-1089
    Full Text

  344. 344

    Kazuo Chin. (2006) Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 43:6, 734-737
    CrossRef

  345. 345

    Kosuke Tsukamoto, Akitoshi Ohara. (2006) Temporal Worsening of Sleep-Disordered Breathing in the Acute Phase of Myocardial Infarction. Circulation Journal 70:12, 1553-1556
    CrossRef

  346. 346

    Somers, Virend K., . (2005) Sleep — A New Cardiovascular Frontier. New England Journal of Medicine 353:19, 2070-2073
    Full Text

Letters